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 Fungal polyketides are natural products assembled by polyketide synthases 
(PKSs), and among this rich class of secondary metabolites are potent toxins, pigments, 
and best-selling pharmaceuticals. Such diverse bioactivities all originate from the same 
core biosynthetic reactions. PKSs catalyze the condensation and modification of small 
acyl substrates to generate complex scaffolds in an iterative and programmed fashion. 
Substrates and intermediates are tethered to the PKS and delivered to client domains that 
act repeatedly during the synthesis of a single product molecule. Non-reducing PKSs 
(NR-PKSs) generate linear poly-β-ketone intermediates of a specific chain length that are 
subsequently cyclized in a regiospecific fashion and released to give aromatic mono- and 
polycyclic products, many of which are further modified by downstream enzymes. 
 In the last decade, significant effort in the Townsend lab has been devoted to 
understanding NR-PKS programming, a challenging task given the size of these 
megasynthases and the lack of isolable intermediates in the native producers. Previous 
work pioneered a domain deconstruction approach, whereby NR-PKSs are dissected at 
the genetic level to generate mono- and multidomain fragments through heterologous 
expression. Reconstituting these fragments in vitro enables examination of specific 
domain combinations, shedding light on the mechanisms and programming of individual 
catalytic domains. Domain deconstruction has also provided opportunities to obtain 
atomic-resolution structures of NR-PKS domains. 
 Some NR-PKSs contain an embedded C-methyltransferase (CMeT) that installs 
one or more methyl groups onto the polyketide scaffold, but little was known about the 
mechanism or programming of this enzymatic alkylation. In this work, we extend the 
 iii 
domain deconstruction approach to explore NR-PKS C-methylation, particularly in the 
biosynthesis of citrinin, a fungal toxin. In addition to biochemical experiments designed 
to tease apart how different CMeTs install different methylation patterns, we solved the 
first crystal structure of a NR-PKS CMeT and found characteristic features that are 
consistent across all known PKS CMeTs, from marine bacteria to pathogenic fungi. 
Finally, we identified an editing hydrolase in gene clusters with CMeT-containing NR-
PKSs and propose that it serves to maintain efficient biosynthesis by removing off-path 
intermediates from the PKS in trans. The work in this dissertation will serve as a 
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1.1. Introduction to natural product biosynthesis 
 Almost every crevice on the face of the planet has been found to be home to 
microbial life.1 It is a testament to the power of evolution by natural selection that 
organisms can occupy such diverse realms only to find stiff competition for survival. 
Like all life, microbes take in nutrients and produce molecules necessary for survival 
through metabolic pathways – interconnected collections of genes, proteins, and chemical 
reactions. Primary metabolism includes the pathways necessary to produce essential 
metabolites; amino acids for protein biosynthesis, lipids for membrane formation and 
energy storage, and nucleic acids for replicating genetic information are all examples of 
primary metabolites.2 A deficiency in one of these pathways is frequently detrimental, 
and often lethal, to the organism. 
 Microbes are also an astonishingly rich source of secondary metabolites (Figure 
1.1).3 Broadly, these are molecules not essential for basic cellular functions but which 
provide a survival advantage. Secondary metabolites serve their producers by inhibiting 
growth of competitors, scavenging scarce nutrients, facilitating infection of a host, or 
transmitting information to neighboring cells.4 Mankind has been using naturally-derived 
substances rich in secondary metabolites for millennia, generally for therapeutic effects 
like the pain relief associated with chewing a particular tree’s bark. Only for the last 
century or so, have microbes been exploited for their wealth of secondary metabolites, 
initially through the fermentation and extraction of isolated strains of bacteria or fungi. 
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Figure 1.1: Examples of natural products from several classes. Microbial natural products are as diverse 
in their bioactivities as in their structures. Erythromycin, streptomycin, and penicillin are antibiotics, 
whereas aflatoxin and citrinin are potent toxins for humans and livestock. Lovastatin led to the 
development of anti-hypercholesteremia drugs and morphine and its derivatives are widely (and perhaps 
overly) used for pain management. 
 
 Early efforts led to the development of several classes of antibiotics, cholesterol-
lowering statins, immunosuppressants, and chemotherapeutics.5 As technology has 
advanced, the scope of microbial natural products has widened. Genomic efforts have not 
only identified the genes and proteins responsible for the production of known molecules, 
but also have illuminated a greater capacity for biosynthesis than had been appreciated.6, 7 
Fortunately, the genes of a given biosynthetic pathway in bacteria and most fungi are 
almost always physically clustered on the chromosome, enabling bioinformatic 
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applications like antiSMASH to rapidly identify potential biosynthetic pathways and 
predict their products.8 The advantages of clustering include common regulation and 
expression of all genes in the cluster and ease of horizontal transfer.9 The latter is thought 
to be partially responsible for the diversity of natural products, as clusters can be rapidly 
duplicated, spread, and diversified across many organisms, with each retaining the 
variants most suitable for its own ecological niche.10 Furthermore, metagenomic analyses 
have cataloged the biosynthetic pathways found in specific environments without the 
need for axenic cultures or even growth under laboratory conditions, a bottleneck that 
otherwise restricts ~99% of microbes from study.11, 12 
 The overwhelming amount of data, and the number of unexplored biosynthetic 
pathways, has renewed interest in exploring natural products as a source of therapies.13 
As a group, these molecules tend to have complex scaffolds often difficult to replicate 
synthetically and occupy regions of chemical space likely enriched for biological activity. 
In fact, 0.3% of known polyketide scaffolds had resulted in a drug as of 2005, a 300-fold 
enrichment over traditional pharmaceutical screens.14 Their biosynthetic pathways also 
have a number of features that make them attractive for engineering efforts, inspiring 
thoughts of “plug-and-play” cassettes that can be used to produce novel products cleanly 
and efficiently.15 How researchers can best co-opt these biosynthetic pathways remains 
an open question, however newer tools and technologies are poised to deepen our 
understanding of the “programs” that biosynthetic enzymes follow to make a given 
product. The work presented in the following chapters is a contribution to untangling the 
programmed biosynthesis of fungal polyketides, particularly those that are C-methylated. 
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1.2. Polyketides and iterative catalysis 
 Three major classes of natural products share the same core biosynthetic logic: 
polyketides, fatty acids, and non-ribosomal peptides.16, 17 In each case, the core scaffold 
of the natural product is built through sequential rounds of condensation and modification 
of simple substrates, and reactions are carried out on intermediates covalently bound to a 
carrier protein (Figure 1.2). Polyketide synthases (PKSs) and fatty acid synthases (FASs) 
include acyl carrier proteins (ACPs) while non-ribosomal peptide synthetases (NRPSs) 
use a peptidyl carrier protein. A post-translational modification of a conserved serine 
residue to form a phosphodiester with the phosphopantetheine moiety of Coenzyme A 
(CoA) converts apo-ACP to holo-ACP, the active form of the carrier protein.18 This 
modification occurs at one end of a small four-helix bundle, giving the carrier protein a 
flexible arm, approximately 20 Å long. The phosphopantetheinyltransferases (PPTases) 
that catalyze the modification are found as both discrete enzymes or as embedded 
domains in larger proteins, often the same protein that contains the ACP. Substrates and 
intermediates are covalently bound through a thioester bond with the free thiol on the arm 
and can be delivered into the active sites of other enzymes or domains. Tethering these 
species to the carrier protein also greatly increases their effective concentration, 
preserving the metabolic investment used to synthesize complex intermediates. 
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Figure 1.2: Activation of an ACP with phosphopantetheine. The solution structure of the excised ACP 
monodomain from PksA is shown being activated by a non-specific PPTase to install the 
phosphopantethein arm.19 In schematic representations, the arm is often signified with a short, wavy line 
ending with a thiol or acyl thioester. PPTases are Mg2+-dependent, and several are promiscuous allowing 
for the loading of synthetic analogs, a valuable tool for probing natural product biosynthesis. 
 
 FASs and PKSs share the same set of reactions for condensation and 
modification20, in addition to carrier protein-tethered intermediates (thorough discussion 
of NRPSs is available elsewhere21). The sequence of reactions can be carried out by an 
enzyme with multiple catalytic domains encoded in its primary sequence (Type I) or 
multiple discrete enzymes that form a complex in solution (Type II).22, 23 Type II FASs 
and PKSs are found in bacteria, while Type I multienzymes are present in bacteria, fungi, 
and animals and include the PKSs used in this work.24 Small acyl intermediates are 
loaded onto specific acyltransferase (AT) domains and then loaded onto the ACP for 
transfer to a conserved cysteine in the ketosynthase (KS), the workhorse domain of PKSs 
and FASs. The ACP is then loaded with a malonyl extender unit, or derivative, which it 
delivers to the KS where decarboxylative Claisen condensation occurs. The ACP-bound 
nucleophile attacks the KS-bound acyl intermediate, resulting in a head-to-tail assembly 
of two-carbon units per round of extension. 
 The fate of the newly extended acyl intermediate depends on the presence of 
tailoring domains in the PKS/FAS and the programmed pathway (Figure 1.3). The most 
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common modification or tailoring step is reduction of the β-ketone, either to the 
corresponding alcohol by a ketoreductase (KR), the α,β-unsaturated thioester by a 
dehydratase (DH), or the completely reduced methylene by an enoyl reductase (ER). 
FASs rest at one end of a spectrum of reduction; they generally reduce the β-ketone 
following each round of extension to generate a completely saturated fatty acid, with 
fungal and bacterial PKSs ranging from completely non-reducing to partially and highly-
reducing.25  
 
Figure 1.3: Schematic of FAS and PKS condensation and tailoring. The AT domain loads extender 
substrates onto the holo-ACP, which when delivered to the KS allows for decarboxylative Claisen 
condensation. The resulting substrate, now two carbons longer, can go through all, some, or none of the β-
reductions, depending on available domains. In FASs, the entire suite of reductive domains is used, in HR-
PKSs, only programmed domains are used, and in NR-PKSs, none are used as none are present, and the 
extended substrate is loaded back onto the KS for another round of condensation. 
 The architecture and function of the condensing and modifying domains can be 
further categorized as modular or iterative. Bacterial modular PKSs (modPKSs) are 
comprised of multiple “modules” or sets of catalytic domains that complete a single 
round of condensation and modification before handing off the intermediate to a 
downstream module, like an assembly line.14 The sequence of the first modular PKS, 
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responsible for erythromycin biosynthesis, serves as a canonical example.26 A single gene 
can encode one or more modules, and ordering the modules from N- to C-termini reveals 
a relationship between domain architecture and product termed co-linearity. Because 
synthesis also proceeds from N- to C-termini, one can predict the PKS product by 
inspecting the modifying domains present in each module (Figure 1.4), however there are 
known deviations from co-linearity. 
 
Figure 1.4: Biosynthesis of the erythromycin aglycone is the canonical example of co-linearity in 
modPKSs. Shown as a “spaghetti” diagram, each module’s ACP has the intermediate present upon 
completion of that module’s cycle. Correlating reductive domains with the functionality at the β-carbon is 
textbook co-linearity. The final linear intermediate is macrolactonized by the TE to release the aglycone for 
downstream oxidation and glycosylation, ultimately yielding erythromycin. 
 Upon elucidation of their domain architecture, modPKSs were obvious targets for 
engineering. Initial efforts perturbed biosynthesis by inactivating a single tailoring 
domain of a module, for example a KR, and looking for retention of the previously 
reduced ketone.27 Swapping of entire modules has also been accomplished28, inspiring 
the term “combinatorial biosynthesis,” but these efforts have not been as facile as first 
hoped.29, 30 Modules connect through N- and C-terminal helical bundles, and while 
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careful selection of these can improve hybrid modPKS production, structural data at the 
multi-module level will be necessary to achieve productive and general combinatorial 
regimes.31 
 A notable subclass in polyketide biosynthesis is found in the more recently 
discovered trans-AT PKSs.32 These systems are uncommon in the best studied bacterial 
polyketide producers, Actinomycetes, but may represent over a third of all modPKSs; 
they are most commonly found in unusual or uncultured branches of the bacterial family 
tree, particularly symbionts, pathogens, and marine-dwelling bacteria.33 Even before 
trans-AT polyketides were understood to be a separate class, products like mupirocin 
were successfully commercialized as antibiotics used to treat drug-resistant infections.34 
As the name implies, these modPKSs lack AT domains within the modules and instead 
use one or a few discrete AT domains in trans to supply each module with the required 
extender substrates. To add to their peculiarity, the types of trans-AT modules (several 
dozen and counting) greatly outnumber those found in canonical cis-AT modPKSs (~8) 
and are so rich in uncharacterized domains lacking any sequence homology that many 
modules cannot be assigned a function. Among those that have been characterized, 
activities include O-methylation, β-γ dehydration, oxygen insertion, and β-branching.32, 
35, 36 Trans-AT PKSs most certainly contain yet more undiscovered biosynthetic novelties 
and deserve significant attention moving forward. 
 Iterative PKSs (iPKSs) can be found in bacteria, fungi, and even humans 
(accounting for mammalian FAS). They differ from their modular cousins by reusing the 
same set of catalytic domains for each round of extension and modification. 
Unfortunately, this behavior makes predicting the PKS product very difficult as the 
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number of condensations and the subsequent degree of modification is obscured by their 
iterative function, as not all domains may be used every cycle. Deciphering the 
mechanisms by which programmed biosynthesis is enforced remains a primary goal of 
the field, even though several iPKSs have been extensively studied.37-40 
 
1.3. Fungal non-reducing polyketide synthases 
1.3.1 Overview 
 
 Non-reducing PKS (NR-PKS) products were some of the earliest isolated 
polyketides, but the basis for their biosynthesis was unknown until relatively recently, 
even though non-reduced polyketides are of considerable concern as human or 
agricultural toxins.20, 41 Aflatoxins, a collection of products whose biosynthesis is 
dependent on the NR-PKS PksA, are hepatotoxic and carcinogenic compounds produced 
by a number of filamentous fungi, notably Aspergillus species.42 Infection of crops by 
aflatoxin-producing species results in accumulation of these mycotoxins that can induce 
acute or chronic harm to livestock and humans that consume these foods.43 Rigorous 
monitoring can reduce the risk of aflatoxin contaminated products reaching the food 
supply, but many regions of the world lack the resources or infrastructure to carry out 
such monitoring. Citrinin, one of the oldest known polyketides, also poses a human 
health risk. It is a nephrotoxin commonly found in fermented rice products, as the 
Monascus and Aspergillus species that are used to produce red pigments during 
fermentation often co-produce citrinin.44 The NR-PKS-derived phytotoxin cercosporin is 
also of particular relevance to agriculture. Cercospora species infect dozens of high-value 
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crops, including beats, soybeans, coffee, and tobacco, causing a characteristic “leaf 
spot.”45 Cercosporin is exported from the fungus and serves as a photoactivator that 
converts oxygen to the singlet state, which oxidizes plant membranes to cause nutrient 
leakage and enables further fungal pathogenicity.46 
 Applying genetic, biochemical, and structural techniques to probe iPKS 
programming has been a longstanding effort in the Townsend lab, particularly in the 
context of fungal NR-PKSs. Identifying and characterizing the NR-PKSs responsible for 
toxin production can serve efforts to limit contamination and crop loss, and the dozens of 
reactions catalyzed during NR-PKS biosynthesis offer a number of targets for 
engineering biosynthesis.  
1.3.2. Unveiling NR-PKS programming through domain dissection 
 The first breakthrough in efforts to explore NR-PKS biosynthetic programming 
came with the discovery that domain boundaries could be identified through 
bioinformatics. The Udwary-Merski algorithm combines multiple sequence analysis with 
predicted secondary structure and local hydrophobicity to score each residue in the 
megasynthase (Figure 1.5).47 High scores indicate that a position is conserved, in a α-
helix or β-sheet, or likely buried in the core of a domain, but low scores reflect 
interdomain linker regions that are likely to be flexible. With the domain boundaries 
identified, sequences of mono- or multidomain fragments can be inserted into 
heterologous expression vectors. The method was first applied to PksA, the aflatoxin NR-
PKS from A. parasiticus, and led to the first in vitro reconstitution reactions of a NR-
PKS.37 
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 Domain dissection was then applied to several additional NR-PKSs, including 
CTB1 (cercosporin, C. nicotianae48), Pks1 (tetrahydroxynaphthalene, Colletotrichum 
lagenarium49), Pks4 (bikaverin, Gibberella fujikuroi50), wA (melanin, A. nidulans51), and 
ACAS (atrochrysone carboxylic acid, A. terreus52). Though not every domain fragment 
could be obtained for each NR-PKS, a sufficiently large collection was assembled to 
conduct combinatorial domain swaps.53, 54 The following sections describe the lessons 
learned from these experiments and others, and serve as the foundation for the work 
described in subsequent chapters. 
 
Figure 1.5: Example output from the Udwary-Merski algorithm. Each residue in PksA is represented 
along the x-axis, with the residue’s score on the y-axis. The domain boundaries are marked by the gray 
lines. The absolute value of the score is less predictive than the local maxima and minima due to the 
varying levels of conservation from domain to domain. For example, KS domains are highly conserved 
across all PKSs, whereas lower conservation of SAT domains in NR-PKSs can be attributed to the different 
starter units selected (or presence of an upstream starter unit supplier). Using the local minima to guide the 
selection of domain boundaries allows for heterologous expression of mono- and multidomain fragments. 
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1.3.3. Initiation and Extension 
 NR-PKSs share the essential domains for decarboxylative Claisen condensation – 
KS, ACP, and malonyl-CoA:ACP acyltransferase (MAT) – common to all PKSs, but also 
contain unique domains. In modPKSs, the acyl species that serves as the electrophile in 
the first condensation reaction, termed the starter unit, is generally loaded onto the 
enzyme by an intiation module.31 This small module consists of either a loading AT or 
KSQ domain (a mutated KS capable of decarboxylation but not condensation) paired with 
its own ACP that transfers the starter unit to the downstream module’s KS for 
condensation.55 Highly-reducing (HR-) and partially-reducing PKSs (PR-PKSs) have no 
N-terminal loading domain, but instead the starter unit is directly loaded onto the KS 
from the corresponding acyl-CoA.56, 57 
 NR-PKSs have a dedicated starter unit:ACP transacylase (SAT) that selects and 
loads the starter unit onto the ACP (Figure 1.6).58 Such a specialized domain had been 
hypothesized on the basis of radiolabel studies showing that acetyl-CoA was used 
directly rather than through decarboxylation of malonyl-CoA.59 Previous work in the 
Townsend lab identified an N-terminal domain of unknown function with sequence 
similarity to other ATs that selectively transferred starter units to the ACP.60 Many NR-
PKSs use more elaborate starter units that are provided by a dedicated upstream FAS or 
HR-PKS, and more recent work has suggested that the SAT domain also serves as a 
protein adapter to facilitate transfer from the upstream ACP to the NR-PKS ACP.61 
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Figure 1.6: Representative example of NR-PKS biosynthesis. PksA accepts a hexanoyl starter unit from 
a dedicated pair of yeast-like FASs that form a complex with PksA.62 The starter unit is transferred to the 
KS, and seven rounds of iterative condensation produce a C20 poly-β-ketone intermediate that is 
regiospecifically aldol cyclized from C4-C9 and C2-C11 by the PT domain. The bicyclic intermediate is 
released by TE-catalyzed Claisen cyclization to the noranthrone. A series of complex oxidative 
rearrangements results in aflatoxin B1. 
 Once the starter unit is transferred to the KS, condensation to the full chain length 
is rapid and processive, with no detectable intermediate chain lengths.63 The growing 
intermediate is likely retained in the active site throughout by rapid transfer from the 
ACP back to the KS following condensation. Combinatorial swaps indicate that chain 
lengths are controlled predominantly by the KS until the intermediate approaches the 
programmed length, at which point downstream domains, particularly the product 
template (PT), appear to participate as well.54 In the absence of any downstream domains 
a variety of derailment products are observed. These species tend to be full-length 
intermediates that spontaneously cyclize to a number of products also seen in other 
examples of non-reduced polyketide biosynthesis.54, 64 After the triketide stage, 
intermediates can also spontaneously release themselves from the ACP thioester by C-O 
bond formation yielding a pyrone. 
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1.3.4. Regiospecific cyclization and release 
 The second unique feature of NR-PKSs is the PT, which catalyzes regiospecific 
aldol cyclization of the full-length ACP-bound poly-β-ketone intermediate to give a 
mono- or bicyclic intermediate, with loss of one or two water molecules.37 The PT 
domain, while not similar by sequence, adopts a double hot dog fold resembling the fold 
found in DH domains in other iPKSs, consistent with the formal dehydration carried out 
during PT-mediated cyclization.65 Three common cyclization patterns have been 
observed giving rise to monocyclic C2-C7, and bicyclic C4-C9/C2-C11 and C6-C11/C4-
C13 intermediates. An additional non-natural C8-C3 pattern has been induced through 
mutation of a PT domain.66 
 Once cyclized, the acyl-ACP intermediate is a substrate for thioesterase (TE)-
catalyzed release. TEs operating in PKS and NRPS biosynthesis have a number of 
functions beyond canonical hydrolysis. NR-PKS TE domains have been shown to release 
products through Claisen cyclization, lactonization, and hydrolysis, and Pks1 TE also has 
deacetylase activity.67-69 Additionally, TEs often serve a role in editing non-productive or 
off-path intermediates. For example, PksA TE hydrolyzes hexanoyl intermediates from 
the ACP but not malonyl extender units, presumably to prevent stalling of the PKS in the 
event of malonyl decarboxylation without extension or improper loading of hexanoyl to 
the ACP instead of malonyl or the growing KS-bound intermediate.63 
1.3.5. Unexplored NR-PKS domain functions 
 The domain deconstruction and in vitro reconstitution reactions discussed above 
provided a set of “rules” for how starter unit selection, extension, cyclization, and release 
were carried out. Other aspects of NR-PKS biosynthesis were yet to be examined at the 
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outset of the work presented herein. The most common NR-PKS domain not included in 
the initial combinatorial swaps was a putative C-methyltransferase (CMeT), which can be 
found in up to a third or more of NR-PKSs, depending on the organism.70 These domains 
install one or more methyl groups during chain elongation, but the mechanism and 
programming of methyltransfer were not clear at the outset of this work. That NR-PKS 
C-methylation remained unexplored despite representing the simplest example of 
programming emphasized the difficulty of characterizing individual intermediates in 
iPKSs. Expanding domain deconstruction and combinatorial domain swaps to explore 
how C-methylation is programmed was a logical extension of previous work. 
Some NR-PKSs also contain a C-terminal reductase (R) domain in place of a TE, 
thought to catalyze NAD(P)H-dependent hydride transfer that reduces the acyl-ACP 
thioester to an aldehyde product and free holo-ACP.70 The first R domains were 
identified in yeast lysine biosynthesis and later in the NRPS-based biosynthetic pathway 
for myxochelins.71-73 In those cases, both two and four electron reductions are catalyzed, 
though such secondary reductions in polyketide biosynthesis are not known at this time. 
Though relatively few examples of NR-PKS R domains are known, their aldehyde 
products often serve as handles for subsequent cyclization or transamination.74-76 No 
known examples of R-catalyzed editing are known, however. The fundamental question 
of how R-containing NR-PKSs remove off-path intermediates was also of particular 




1.4. Structural lessons and future directions in natural product 
biosynthesis and engineering 
 Despite the phenomenal expansion in knowledge about polyketide biosynthesis 
during the last two decades, many questions remain, particularly surrounding the 
mechanisms of programming and their structural basis. Crystal structures of individual 
domains have clarified their folds and active site organizations, and some structural 
information – either direct of through homology – is available for almost all NR- and 
HR-PKS domains. Early achievements for iPKS structural fragments included a DEBS 
KS-AT didomain, the PksA PT and TE, and several β-tailoring domains.65, 67, 77-80 Many 
of these structures include bound substrates or substrate mimics, but not all substrates are 
amenable to crystallographic studies, especially the highly-reactive poly-β-ketone 
intermediates found in NR-PKSs though some pseudo-substrates have been visualized.81 
 Monodomain structures have been incredibly informative when addressing 
catalytic mechanisms of individual domains, but they do not capture the larger scale 
mutlidomain organization or conformation changes in iPKSs. Crystallography has been 
used to investigate cross-linked structures where an ACP is covalently linked to a client 
domain in both FAS and PKS examples, however, demonstrating consistent themes in 
ACP:client domain interfaces.82, 83 The landmark crystal structure of mammalian FAS by 
Maier, Leibundgut, and Ban provided the first thrilling glimpse into the three-
dimensional organization of PKSs.84 The megasynthase was revealed to be a head-to-
head dimer with primary interfaces between the KS and DH domains, affectionately 
referred to as a “gingerbread man.” The ACP was not visible, however, as a result of its 
inherent mobility and the lack of any tools to force docking at a single client domain. 
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Maier and coworkers recently published the composite structure of a HR-PKS involved 
in mycocerosic acid biosynthesis in Mycobateria that revealed conformational coupling 
in the β-tailoring domains, leading to a proposal for how programmed processing 
occurs.85 
 The most relevant development in structural biology for addressing complete 
PKSs has been the increasing accessibility and resolution of cryo-electron microscopy 
(cryo-EM) techniques. The first complete module from a bacterial modPKS, PikAIII in 
pikromycin biosynthesis, was reported in 2014 with back-to-back publications.86, 87 In 
addition to the structure of a complete module (KS-AT-KR-ACP), the authors were able 
to selectively load individual domains with substrates to capture three different 
conformational states representing substrate loading, extension, and β-reduction that 
revealed substantial conformational movement of not only the ACP but also the AT and 
KR domains. Combined with an unusual orientation of the KS-AT portion, compared to 
mFAS or DEBS KS-AT structures, these findings were difficult to contextualize. 
Because there are so few structures of intact PKSs, it is unclear whether these unexpected 
conformations are common or rare among modPKS. As cryo-EM further matures, high-
resolution structures of all classes of megasynthases will become more common, creating 
a library of PKS architectures in various states of programmed biosynthesis. The 
marriage of cryo-EM structures with site-specific cross-linking, high-resolution mass 
spectrometry, and improved heterologous expression systems promises that the next 
decade will bear exciting developments in our understanding of these complex nano-scale 
biological factories. The author hopes the contributions in this dissertation to the 
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Chapter 2: Functional and Structural Analysis of Programmed 
C-Methylation in the Biosynthesis of the Fungal Polyketide 
Citrinin 
 
This chapter was adapted with permission from P. A. Storm, D. A. Herbst, T. Maier, C. 
A. Townsend, Cell Chem. Biol. 2017, 24, 316-325. 
 
2.1.     Introduction 
 PKSs and fatty acid synthases (FASs) utilize common strategies to produce an 
enormous number of natural products with highly diverse chemical scaffolds, including 
pigments, environmental toxins, and pharmacologically active substances.1, 2 Simple 
precursor acyl substrates are tethered to the acyl carrier protein (ACP) by 
thioesterification of a post-translationally installed phosphopantetheine arm. They are 
then extended by the ketosynthase (KS) through a determined number of decarboxylative 
condensation reactions with ACP-bound malonyl extender units supplied by the malonyl-
CoA:ACP transacylase (MAT). In many cases, the newly extended intermediate is 
delivered to additional tailoring domains that perform programmed modifications at the 
α- or β-carbon. Modular PKSs (modPKSs) generally have a distinct module for each 
round of extension and modification, whereas iterative PKSs (iPKSs) use the same 
domains repeatedly a defined number of times. How iPKS domains control which 
tailoring domains are used after a given round of extension is still largely unanswered and 
poses a significant challenge to engineering efforts. 
 Perhaps the simplest case of programmed tailoring among PKSs occurs during 
iterative C-methylation of fungal non-reduced polyketides, exemplified by the group VI 
and VII, or Clade III, families where a tetra- or pentaketide is C-methylated one or more 
times by an embedded C-methyltransferase (CMeT).3, 4 Each round of extension produces 
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a potentially enolizable nucleophilic α-carbon, but only some such positions are 
methylated. A more complete understanding of how methylation is programmed and the 
structural basis by which methylation occurs will be essential for future efforts to 
rationally influence product methylation patterns. Site-selective polyketide C-methylation 
would be a powerful tool to engineer new biosynthetic pathways, and many 
methyltransferases can accept SAM analogs with larger alkyl donors, further expanding 
potential scaffolds.5 
 We selected PksCT as an initial candidate to explore non-reducing PKS (NR-
PKS) C-methylation.6 Responsible for the first isolable intermediate in citrinin (1) 
biosynthesis7, PksCT produces a triply methylated pentaketide that is C2-C7 cyclized by 
the product template (PT) domain and released as the benzaldehyde (2) by the C-terminal 
reductase domain (R) (Figure 2.1).  
 
Figure 2.1: Proposed biosynthesis of 2 by PksCT. The domain architecture of PksCT is shown (top), 
with bold arrows indicating points of dissection (black: always used, gray: not used for CMeT-R 
didomain). Mal indicates a unit of ACP-bound malonyl used for decarboxylative condensation prior to 
methylation. Necessary domains and substrates are shown above and below the reaction arrows. 
  
 Previous efforts to understand NR-PKS programming have benefited greatly from 
a deconstruction approach that allows for the extension domains to be separated from the 
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tailoring domains.8-10 A growing number of excised PKS domains have been structurally 
characterized, providing the molecular details of catalysis and substrate selection.11 We 
sought to expand this experimental approach to PksCT in order to isolate CMeT domain 
activity and explore the structural basis for NR-PKS C-methylation programming. 
 
2.2.     Results 
2.2.1.     Domain Deconstruction and Reconstitution of PksCT 
 Using the Udwary-Merski algorithm (UMA)12 to recognize interdomain linker 
regions in a set of related proteins, a domain deconstruction approach was applied to 
PksCT and used to generate mono- and multidomain fragments (Figure 2.2). A complete 
list of analyzed sequences and UMA parameters is available in Appendix A.  
 
Figure 2.2: Domain deconstruction of PksCT using the Udwary-Merski algorithm. A curated list of 
NR-PKSs with conserved domain architecture was submitted to UMA, which scores each position of each 
entry based on sequence conservation, predicted secondary structure, and local hydrophobicity. Low scores 
indicate likely linker regions and were used to identify domain boundaries for preparation of mono- and 
multi-domain expression constructs. 
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 All constructs gave soluble protein except for those containing the SAT domain in 
initial expressions. When multiple alternate domain boundaries did not improve 
expression, we reassessed the reported exons using the FGENESH exon prediction 
suite.13 These results suggested alternate exon boundaries, which would include a 
conserved Trp195 in the SAT domain that was not present in the original annotated 
sequence. Total RNA was isolated from wild-type Monascus purpureus grown under 
citrinin producing conditions.6, 14 The cDNA was synthesized, and a region containing the 
exon boundaries was amplified and subcloned. Five clones were sequenced and all 
verified that the revised prediction generated the correct exon boundaries (See Appendix 
A). We propose an update to GenBank: AB167465, joining gene fragments 1197-1835 
and 1892-9034. PksCT residue numbering used hereafter reflects this revision. 
 Earlier reports speculated that PksCT could use several potential starter units15, 
but heterologous in vivo extracts suggested an acetyl starter.7 We confirmed this mode of 
initiation in vitro using a radiochemical assay.16 PksCT SAT was capable of loading an 
acetyl starter unit from [1-14C]-acetyl-CoA and transferring it to PksCT holo-ACP (See 
Appendix A). We then conducted a series of reconstitution reactions to identify the 
activity of the PksCT CMeT domain (Figure 2.3). Each individually expressed and 
purified fragment was combined as indicated with all of the expected substrates. Acetyl 
and malonyl units were included as the N-acetylcysteamine thioesters (SNAC), which 
serve as substitutes for the CoA thioesters used in vivo.10 Stock solutions of SAM and 
NADPH were freshly prepared. 
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Figure 2.3: In vitro reconstitution of PksCT. (A) HPLC absorbance traces are shown at 280 nm for the 
combination of domains indicated to the right. Traces are vertically offset and peak 3 is truncated for 
clarity. (B) Spontaneous pyrone release of the intermediates as tri-, tetra-, and pentaketide pyrones allows 
for observation of the intermediates during each cycle. See Appendix A for UV-Vis and UPLC-ESI-MS 
data. 
 
 The minimal PKS, SAT–KS–MAT and holo-ACP, with acetyl and malonyl 
substrates primarily generated triketide 3. Upon addition of PT, the product profile was 
not substantially different and no C2-C7 cyclized product was observed, even after 
attempts to chemically release any potentially cyclized intermediate with base or 
cysteamine.17 Addition of CMeT and SAM to the minimal PKS, however, resulted in the 
loss of 3 but the appearance of four new species corresponding to spontaneous pyrone 
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release of methylated tri-, tetra-, and pentaketides 4, 5, and 6. The pentaketide 6 eluted as 
two peaks, identical by mass, that appear to be diastereomers as each collected peak 
equilibrates to the same two components upon isolation and reinjection. The minimal 
PKS reactions also contained small amounts of 7, having a mass consistent with a singly 
methylated form of 3. The disappearance of 7 in reactions containing CMeT suggests that 
it results from an on-pathway intermediate to 4, 5, and 6, and is discussed in detail below. 
 Full extension of the polyketide chain appears to rely upon the correct 
methylation of the growing linear intermediate, a feature seen previously in studies of the 
highly-reduced polyketide lovastatin.18-20 This series of intermediates indicates that 
methylation occurs at the thioester α-carbon iteratively following each extension and not 
processively on a fully elongated pentaketide. These methylated derailment products are 
observed in the presence of the PT and R domains as well. With all domains, AcSNAC, 
MalSNAC, SAM, and NADPH present, the expected post-PKS aldehyde 2 was observed 
also, albeit in low yield. 
 Several efforts to improve the efficiency of reconstituted PksCT were attempted, 
including addition of methylthioadenosine nucleosidase (MTAN)21 to hydrolyze the 
potentially inhibitory SAH co-product or inclusion of Mg2+, a cofactor used by some 
methyltransferases.22 Previous work has demonstrated that NR-PKS deconstruction 
reduces the yield of post-PKS product and increases the abundance of derailment 
products.10, 23 In the case of deconstructed PksCT, it is possible that transfer of 
methylated polyketides from the KS active site to the CMeT active site allows for 
racemization of the methyl groups. Whether the KS, PT, or R domain active sites are 
structured for a specific methyl stereochemistry, and whether polyketides with scrambled 
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methyl stereochemistry are inhibitory, is currently unknown. Additionally, in vivo 
experiments of citrinin biosynthesis indicate that co-expression of an adjacent gene, 
encoding the hydrolase CitA, significantly improves titres of 2, though the specific role 
of CitA is still unclear.7 
 
2.2.2.     Structure of PksCT CMeT in complex with SAH 
 The 1.65 Å crystal structure of the CMeT domain reveals an organization of two 
subdomains with the active site located at their interface (Figure 2.4). PksCT CMeT was 
co-crystallized with the stable co-product S-adenosylhomocysteine (SAH) in 
rhombohedral space group H3 containing one protomer per asymmetric unit (Appendix 
A), the structure was solved by SAD phasing and refined to R/Rfree of 0.19/0.22. 
 
Figure 2.4: Crystal structure of PksCT CMeT in complex with SAH. PksCT CMeT is organized into an 
N-terminal linker (gray), and N-terminal subdomain (purple), and a C-terminal subdomain (yellow). The 
active site is located at the subdomain interface, and Fo – Fc omit difference density at 2.5σ level is shown 
for SAH. 
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 The 202 amino acid (aa) C-terminal subdomain (residues 1959-2160) reveals a 
Class I methyltransferase fold, which is the most common methyltransferase fold in 
natural product biosynthetic enzymes, despite diverse acceptor substrates and low 
sequence conservation.22, 24 The closest structural homologs are the SAM-dependent 
methyltransferase from Aquifex aeolicus (unpublished, PDB: 3DH0), the 
methyltransferase domain of bacterial-AvHen1-CN (PDB: 3JWJ)25, a putative 
methyltransferase from Sulfolobus solfataricus (unpublished, PDB: 3I9F), NodS from 
Bradyrhizobium japonicum WM9 (PDB: 3OFK)26, and the methyltransferase domain of 
bacterial-CtHen1-C (PDB: 3JWG)25 with a Cα rmsd of 2.0-2.4 Å and 160-195 aligned 
residues. The catalytically inactive pseudo-methyltransferase (ΨCMeT) of the human 
fatty acid synthase (FAS) aligns with a Cα rmsd of 2.5 Å (158 aligned aa) and is the 
closest structural homolog in carrier protein-dependent multienzymes.27 The C-terminal 
subdomain integrates into the N-terminal subdomain through a region around helix 15 
that forms the base of the ligand binding tunnel, resembling an open palm (“palm helix 
region”), and is structurally conserved in mammalian FAS 27, 28, but deleted in insect FAS 
and some highly reducing-PKSs (HR-PKS). 
 The 144 aa N-terminal CMeT subdomain (residues 1815-1958) shares an interface 
of 1,515 Å2 with the C-terminal subdomain and adopts an uncharacterized helical fold 
(Figure 2.5A). Such N-terminal subdomains of Class I methyltransferases that cap the 
SAH/SAM-binding pocket often serve a role in acceptor substrate selection.29 In the 
related mammalian FAS multienzymes, which comprise catalytically inactive ΨCMeTs 
domains and provide the only structural depiction of CMeT integration into a 
multienzyme, this region is considerably truncated and disordered.27, 28 Nevertheless, the
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N-terminal CMeT subdomains in FASs reveal helices at equivalent positions to helix 4, 7, 
and 9/10 with a Cα rmsd of 2.5 Å over 42 aligned aa, indicating a common evolutionary 
origin (Figure 2.5B). The N-terminal subdomain is connected to the preceding protein 
regions in PksCT by a 30 aa long linker containing two helices and wraps around the C-
terminal subdomain in a groove with an interface area of 1,461 Å2. In mammalian FASs 
27, 28, the N-terminal linker leading into ΨCMeT contacts this domain by appending a β-
strand to the central β-sheet of the C-terminal subdomain (Figure 2.5B). In PksCT, 
however, the N-terminal linker (residues 1785-1814) wraps around the C-terminal 
subdomain in a prominent surface groove (Figure 2.5C). 
 
Figure 2.5: Topology of PksCT CMeT and comparison to FAS ΨCMeT. (A) PksCT CMeT topology 
revealed a previously uncharacterized N-terminal fold. α-helices are numbered, β-strands are numbered 
relative to their position in the respective β sheets B1 or B2, and helix 17 (dotted) is a 310 helix. (B) A 
superposition of the truncated and largely disordered N-terminal subdomain of the animal FAS ΨCMeT 
(porcine: black; human: white) with PksCT CMeT indicates a structural conservation of three helices, 
overlapping with PksCT CMeT helices 4, 7, and 9/10. The ends of disordered regions are indicated by 
small spheres. Secondary structures are assigned according to Figure 2.5B. (C) In PksCT the N-terminal 
linker wraps in a surface groove around the C-terminal subdomain and positions the N- and C-terminal 
linker termini in close proximity to each other, whereas in FASs the N-terminal linker contacts this domain 
in a different location distant to the C-terminal linker terminus. 
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Consequently, in contrast to mammalian FAS, the N- and C-terminal linker ends are 
located in close proximity to each other, indicating an alternate integration of CMeT in 
the PksCT multienzyme. 
 The active site of PksCT CMeT is located at the interface of the N- and C-
terminal subdomains. Most of the active site is formed by the C-terminal subdomain, 
which binds the SAH parallel to the ligand binding tunnel, which is lined with 
hydrophobic residues of the palm helix region. Helix 9 and 10 of the N-terminal 
subdomain contributes four residues to the distal region of the ligand binding tunnel to 
form the opposite face (Figure 2.6), and the highly conserved Tyr1955 splits the active 
site into a tunnel for the SAM co-substrate and the polyketide substrate. Remarkably, the 
homocysteine moiety of the SAH contributes to the formation of a pocket for extended 
substrates, which could accommodate varying polyketide chain lengths during elongation 
cycles 1-3. 
 
Figure 2.6: Active site of PksCT CMeT. (Left) The CMeT active site, as seen from the opening to 
solvent, is formed by the SAH cofactor (magenta) and several conserved residues, which are generally 
hydrophobic. The proposed base needed to deprotonate the α-carbon of the polyketide methyl-acceptor 
substrate is formed by the His-Glu dyad (green) positioned above the cavity. (Right) A flattened schematic 
of the active site, showing the conserved palm-helix residues. Blue and yellow shading indicates the 
SAM/SAH binding pocket and the acceptor substrate binding pocket respectively, as in Figure 2.5A. 
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 The SAH is tightly bound at an interface of 356 Å2 along one side of the co-
substrate binding pocket via highly conserved residues: A GxGxGG (residues 1992-
1997) motif forms hydrogen bonds with the homocysteine moiety, Asp2019 binds the 
ribose through two hydrogen bonds, and the adenine moiety is positioned in a 
hydrophobic pocket formed by Leu2020 and Ile2045 with a backbone hydrogen bond to 
Ile2045. 
 The active site tunnel reveals a funnel like shape and branches off into the 
extended substrate cavity at its inner end, providing a central channel for Cα substrate 
alignment with regard to different polyketide chain length. The central channel is 
surrounded by a patch of hydrophobic residues; the highly conserved Phe1942 as well as 
Leu1938 line the substrate entrance region and the conserved residues Leu2108 and 
Trp2111 and residues Trp2100, Val2101, Phe2105 of the palm helix would likely interact 
with the linear polyketide substrates. Together, these residues form a hydrophobic patch 
along which the hydrophobic backbone of substrates at various elongation states might 
slide into the active site. Interestingly, the residues involved in the hydrophobic patch are 
highly conserved among other NR-PKS CMeT domains – such as AusA, PkeA, MpaC, 
and DtbA – that install different methylation patterns than PksCT 3, 30, 31, and are 
functionally conserved in both cis- and trans-AT PKSs (Figure 2.7).  
 Although no obvious delineation among the NR-PKS CMeTs correlated with 
observed product methylation pattern, the number of available sequence–product pairs 
may be insufficient to identify specific programming motifs. Furthermore, a phylogenetic 
analysis of CMeT domains across multiple PKS/FAS families clearly demonstrated a 
























































































































































clustered into three groups: trans-AT PKSs, cis-AT and HR-PKSs, and NR-PKSs (Figure 
2.8). Active HR-PKS CMeT domains are nested among cis-AT CMeTs, perhaps 
reflecting similar embedding among reductive domains not present in NR-PKSs.  
 
Figure 2.8: Phylogenetic analysis of 51 CMeT domains from PKSs and FASs. Thirty-eight active 
CMeT domains from PKSs and 13 inactive ΨCMeT from HR-PKSs and FASs were aligned (see Figure 
2.7) and phylogenetically analyzed. Multienzyme family classifications are indicated in colored groups. 
Units are given as amino acid substitutions per site. All sequences are labeled as “protein name (organism 
abbrevation) UniProt number.” The sequences of PksCT reflects the revised exons. (°: endosymbiont of 
listed organism, Ŧ: diketide synthase, *: inactive ΨCMeT domain). 
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2.2.3.     Catalysis by CMeT 
 For catalysis, the α-carbon of the acceptor substrate presumably must be 
deprotonated to generate the enolate nucleophile for SN2-like attack at the methyl donor. 
The invariant residues Tyr1955 and His2067 together with Glu2093 face the ligand 
binding tunnel from opposite sides and are well positioned to act as catalytic residues. 
His2067 forms a hydrogen bridge with Glu2093 and might act as catalytic dyad for 
enolization, as previously proposed for homocitrate synthase.32  
 Reconstitution of the minimal PksCT with the CMeT His2067Ala mutant 
primarily gave triketide 3, matching the profile of the minimal PKS without CMeT 
(Figure 2.9). 
 
Figure 2.9: PksCT CMeT His2067 is essential for methyl transfer but Y1955 is less important. In vitro 
reconstitution of PksCT SAT-KS-MAT and holo-ACP with CMeT mutants show that methylated products 
4, 5, and 6 are not produced by His2067 mutants. Tyr1955 mutants are capable of generating methylated 
triketides, but not pentaketides, suggesting a role for this residue in acceptor substrate binding. Absorbance 
traces are shown at 280 nm for the CMeT variant indicated on the right, and vertically offset with peak 3 
truncated for clarity. 
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This experimental observation demonstrated the essential role of His2067 for efficient 
methyl transfer and supports its likely role as the catalytic base. The more conservative 
His2067Gln mutant33, 34 also produced 3 as a major product in addition to smaller 
amounts of two different triketides 7 and 8 identical by mass, but singly methylated at C-
4 and C-2, respectively. Tyr1955Phe and Tyr1955Ala mutations appeared to have a lesser 
effect on catalysis. Neither produced significant amounts of 3, but instead yielded small 
amounts each of 4, 5, 7, and 8. The reduced amounts of 5 and the absence of 6, compared 
to wild-type, suggest that Tyr1955 may be especially important for methylation of tetra- 
and pentaketide substrates. 
 Based on the experiments above, we propose a mechanism whereby the Glu-His 
dyad deprotonates the ACP-delivered acyl substrate at the α carbon of the thioester, 
forming a transient enolate nucleophile (Figure 2.10). If the orientation of the SAH co-
product in the PksCT CMeT structure reflects a post-transfer conformation, the natural 
(S)-enantiomer of the sulfur center of SAM would point the methyl directly towards the 
interior of the binding pocket, well placed for nucleophilic attack. Following methyl 
transfer, both SAH and methylated acyl-ACP substrates must exit the active site, and the 
proton removed by the His-Glu dyad must exchange with solvent before the CMeT is 
catalytically competent. The order of substrate binding and release and the mechanism of 
proton release are not well understood, though the binding of the subsequent SAM, with 
the positively charged sulfonium, may influence egress of the proton. 
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Figure 2.10: Proposed mechanism of methyl transfer. In the PksCT CMeT active site, His2067 forms a 
catalytic dyad with Glu2093 and deprotonates the α carbon to generate an enolate nucleophile capable of 
SN2-like attack at the methyl donor. Completion of the catalytic cycle by loss of the removed proton to 
solvent is not explicitly shown. R indicates the potential chain lengths described in Figure 2.1. 
 Because 7 was observed also in the absence of CMeT, but appears to be on-path 
to 4, 5, and 6, we speculate that some SAT–KS–MAT may be purified with a 
methylacetoacetyl unit bound to Cys555 in the KS active site. Such a substrate could 
arise from direct loading from methylacetoacetyl-CoA, an intermediate in isoleucine 
catabolism35 or perhaps homologation of KS-bound acetyl by endogenous 
methylmalonyl-CoA during heterologous expression. (For an example of closely related 
biochemistry, see Steyn and Vleggaar, 1984 and Steyn et al., 1981.)36, 37 A single round 
of extension of methylacetoacetyl, followed by spontaneous pyrone formation would 
result in 7, methylated at C-4. The decreased activity of the CMeT His2067Gln mutant 
(Figure 2.9) could allow for a relative increase in 7 and the appearance of 8, methylated 
at C-2, where the first potential methylation is skipped but the second methylation is 
successful. The identity of 8 was subsequently confirmed by comparison to an authentic 
standard, verifying the methyl position. It is known that polyketide extension is 
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exceedingly rapid in NR-PKSs.8, 38 Kinetic competition between chain elongation and 
programmed methylation where the latter is impaired in the His2067Gln mutant could 
lead to expected alkylation at C-4 to be missed. 
 
2.3.     Discussion 
 Methylation is a common and powerful strategy to diversify the structures of 
microbial natural products. iPKSs incorporate C-methyl groups into their product 
scaffolds early in the biosynthetic pathway because the pKa of the methylated position is 
generally never lower or more accessible to enzymatic chemistry than immediately 
following extension to the β-ketothioester, particularly for PKSs that reductively tailor 
the β position. Early indications of the interplay between KS and CMeT domains were 
observed in LovB, where the lack of SAM or CMeT resulted in the accumulation of 
truncated intermediates.18, 20 Recently, it was shown that the LovB CMeT domain 
outcompetes the LovB KR activity by virtue of its higher catalytic efficiency.18 Non-
cognate substrates, due to incorrect modifications in previous cycles, caused significant 
attenuation of activity for the highly specific CMeT, resulting in off-loading of those 
substrates. This finding suggested a role of CMeT as gatekeeper, which has to be passed 
after three of six cycles of polyketide chain extension. Unlike for LovB CMeT, PksCT 
CMeT is not competing with a KR domain and methylates multiple substrates. Therefore, 
PksCT CMeT appears to have a similar function by adding methyl groups as check-point 
tags, which are recognized by PksCT KS, such that a lack of methylation causes release 
of immature products at the triketide stage. Abortive release of an off-pathway 
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intermediate may be useful for NR-PKSs that lack a C-terminal thioesterase domain to 
serve an editing role.38 
 Any future efforts to modulate the pattern of C-methylation in iPKSs may require 
perturbation of both CMeT and KS substrate binding sites. The highly conserved residues 
of the acceptor binding pocket also indicate that methylation programming is determined 
by other features of the active site or acceptor:CMeT complex. That programmed 
methylation is retained even after domain dissection, however, points towards control 
residing in intrinsic features of the CMeT. Additional studies will be needed to identify 
and manipulate these features to control programmed methylation. The existence of gem-
dimethylating CMeTs in trans-AT PKSs39 combined with the iterative action of NR-PKS 
CMeTs show that considerable flexibility is possible, potentially allowing for engineered 
products. 
 Sequence motifs have been identified in other iPKS modification domains that 
allow for prediction of the stereochemical outcome, notably the A- and B-type 
ketoreductase (KR) domains.11 A similar dichotomy for CMeTs, pro-R or pro-S, has not 
been identified. The stereochemistry of methylation could not be inferred from our data, 
and in the context of NR-PKSs this information is lost upon aromatization. Future 
structural work that includes an acceptor substrate should provide greater detail about the 
methyl transfer mechanism. 
 In connection with these findings, a structure of an excised CMeT from a bacterial 
modular PKS was determined contemporaneously and closely agrees with our findings.40 
Briefly, the CMeT domain of CurJ, a module used in curacin biosynthesis, was found to 
install a single methyl group on an elongated, highly-reduced substrate. While some 
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bacterical C-methyl groups are installed by methylating malonyl units prior to 
extension41, CurJ was shown to methylate the post-extension ACP-bound β-ketothioester 
like PksCT CMeT, and had no activity towards malonyl substrate mimics. A structural 
comparison of CurJ CMeT and PksCT CMeT reveals an identical subdomain 
organization, including the helical N-terminal subdomain, though CurJ crystallized as a 
dimer instead of a monomer (PDB: 5THZ). A pairwise structural alignment of PksCT 
CMeT to both protomers of CurJ CMeT returned 1.9 and 2.0 Å over 315 and 321 aligned 
residues.42 The authors were unable to capture CurJ in complex with the polyketide 
substrate, but the active site of CurJ also includes the conserved His-Glu dyad and 
generally hydrophobic residues lining a deep pocket in the cleft between the two 
subdomains. The strong structural similarities between these two CMeT domains, despite 
their disparate sources and substrates, suggest that intrinsic but unknown features of the 
CMeT are responsible for modulating their activity. The effects of the acyl-ACP binding 
to the CMeT are not known, but an attractive area for future study.  
 
2.4. Conclusions  
 Structure determination of the PksCT CMeT domain revealed a characteristic 
organization of the N-terminal subdomain in active PKS CMeT domains and a detailed 
description of residues lining the substrate binding site. Structural alignments to 
mammalian FAS and sequence comparison to modular cis- and trans-AT PKS also 
demonstrate a conserved organization of inactive ΨCMeT domains, commonly observed 
in HR-PKS and FAS and active CMeT domains in all systems. The PksCT CMeT 
structure thus provides a blueprint for the systematic analysis and variation of CMeT 
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functions across all PKS systems. Despite a high degree of conservation at the level of 
subdomain organization and active site assembly, the organization of N-terminal linkers 
in the CMeT domain of the NR-PKS PksCT clearly deviates from those observed for the 
ΨCMeT domain of fully-reducing mammalian FAS, indicating distinct modes of 
integration in the two systems. The exact modes of domain integration (and the extent of 
their conservation) of CMeT domains in systems other than FAS, namely iterative and 
modular cis- and trans-AT PKS, remains to be explored. First indications may be 
obtained from a careful comparison of flanking regions in excised CMeT domains. 
Differences in intrinsic methylation patterns may also be explained through multi-domain 




 Reagents were purchased from Sigma Aldrich (St. Louis, MO) unless stated 
otherwise. Standard molecular biology procedures were used for nucleic acid isolation 
and assembly of expression constructs. Sequencing was done by the Johns Hopkins 
University Synthesis and Sequencing Facility (Baltimore, MD). M. purpureus NRRL 
1596 was received from the ARS, USDA (Peoria, IL) and cultured on PDA plates. 
Genomic DNA was extracted from mycelia using the DNeasy Plant Mini kit (Qiagen, 
Hilden, Germany). Target sequences were amplified by polymerase chain reaction using 
the primers listed in Appendix A. 
 
 44 
2.5.2. Sequence analysis, cloning, and protein production 
 To verify the mRNA sequence of pksCT, M. purpureus NRRL 1596 was grown in 
MC medium following reported methods for citrinin production.6 After 7 days of growth 
at 28 °C, the mycelia were harvested by centrifugation and lyophilized. The mycelial 
powder was ground under liquid nitrogen and total RNA was purified using the RNeasy 
Plant Mini kit (Qiagen, Hilden, Germany) following the manufacturer’s protocol with on-
column DNA digestion. A cDNA library was prepared using 1 µg total RNA with 0.5 µg 
random hexamer (Applied Biosystems, Foster City, CA) and M-MLV reverse 
transcriptase (Promega, Madison, WI) at 37 °C for 1 h. Negative control reactions lacked 
any reverse transcriptase. PCR amplification of the desired exon boundaries was done 
using the cDNA library products directly (2 µL) with primers MpPksCTex1-5 and 
MpPksCT-SAT-3 and Phusion polymerase (New England Biolabs, Ipswich, MA). 
Primers for the constitutively expressed actin gene MpAct5 and MpAct3, based on a 
previous report6, were used as positive controls. The PCR reactions were separated by 
1% agarose gel and the lone product band was ligated into pCR-blunt (Life Technologies, 
Carlsbad, CA) and transformed into DH5α by heat shock treatment. Five clones were 
sequenced using M13F and M13R primers.  
 Domain boundaries and expression constructs are detailed in Appendix A. Each 
construct was transformed to E. coli BL21(DE3) and grown in LB media at 37 °C to 
OD600 of 0.6. The cultures were cooled in an ice bath for 30-60 min, and expression was 
induced with 1 mM IPTG (GoldBio, St. Louis, MO) overnight at 18 °C. Cell pellets were 
harvested by centrifugation for 15 min, at 4,000 x g, 4 °C. Pellets were either flash frozen 
in N2(l) and stored at -80 °C until use, or resuspended immediately in 5 mL/g cell pellet 
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in buffer A (50 mM potassium phosphate, 300 mM NaCl, 10 % glycerol, pH 7.6). The 
slurry was sonicated on ice for 10 x 10 s at 40% amplitude (Vibra-Cell Ultrasonic 
Processor, Sonics & Materials, Inc., Newtown, CT) and the lysate was cleared by 
centrifugation for 25 min at 27,000 x g, 4 °C. The cleared lysate was batch bound to 
Co2+-TALON (Clontech, Mountain View, CA) at 4 °C for 1 h. Purification was 
performed by gravity column and the applied resin was washed with buffer A (10 CV) 
and buffer A + 2 mM imidazole (5 CV) before eluting in buffer A + 100 mM imidazole 
(5 CV). Each domain fragment was dialyzed into reaction buffer (100 mM potassium 
phosphate, 10 % glycerol, pH 7.0) and used immediately or flash frozen in N2(l) and 
stored at -80 °C until use. 
 For crystallization, PksCT CMeT was expressed and initially purified as 
described above, but dialyzed into 25 mM Tris, 5 % glycerol, pH 7.5 (buffer B). A 
secondary purification was performed by applying 60 mg PksCT CMeT to 25 mL Q-
Sepharose Fast-flow resin pre-equilibrated in buffer B. A series of 2 CV step-wise 
washes of buffer B + 0, 10, 50, 100, 150, 200, 300, and 500 mM KCl were then applied 
to the column, with the CMeT eluting in the 50 and 100 mM KCl fractions. These 
fractions were combined, dialyzed into 2 x 1 L buffer B, and concentrated to 10 mg/mL. 
 Selenomethionine-labeled (SeMet) CMeT was prepared by growth in M9 minimal 
media to OD600 = 0.6, at which point the media was supplemented with the following L-
amino acids per 1 L: 100 mg each lysine, phenylalanine, and threonine; 50 mg each 
isoleucine, leucine, and valine; 30 mg selenomethionine.43 The cultures were allowed to 
continue to grow at 37 °C for 15 min before being cooled and inoculated as decribed 
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above. Purification of SeMet CMeT for crystallization was identical to that of the native 
CMeT. 
 
2.5.3. In vitro reconstitution of PksCT and analysis of product formation 
 Protein concentration was determined by Bradford assay (BioRad, Hercules, CA) 
in duplicate using bovine serum albumin as a standard.  Prior to in vitro reactions, ACP 
was activated by Sfp with CoASH and MgCl2 in reaction buffer for 1 h at room 
temperature as previously reported.10 PksCT reconstitution reactions contained 10 µM of 
each included domain with 0.5 mM AcSNAC, 2 mM MalSNAC, 2 mM SAM, 1 mM 
NADPH, and 1 mM TCEP in reaction buffer totaling 250 µL. AcSNAC was prepared 
synthetically and MalSNAC was purified from MatB reactions.38 After 4 h at room 
temperature, the reactions were quenched with 5 µL concentrated HCl and extracted into 
ethyl acetate 3 x 250 µL. The combined organic extracts were dried to a residue and 
resuspended in 250 µL of 20 % aqueous acetonitrile. Extracts were analyzed on an 
Agilent 1200 HPLC with autosampler by injecting 100 µL onto a Prodigy ODS3 column 
(4.5 x 250 mm, 5µ, Phenomenex, Torrence, CA) with 5-85 % MeCN/H2O, with 0.1 % 
formic acid, over 40 min at 1 mL/min. Mass spectrometric analysis was done using a 
Waters Acquity Xevo G-2 UPLC-ESI-MS in positive ion mode, with 5 µL injected on a 
BEHC C18 column and 10-90 % MeCN/H2O, with 0.1 % formic acid, over 10 min. 
 Radiolabel transfer assays were carried out with 10 µM each protein in the above 
reaction buffer. Reactions were initiated with the addition of [1-14C]-acetyl-CoA 
(American Radiolabeled Chemicals, St. Louis, MO) to 50 µM at room temperature for 5 
min and quenched with the addition of 5X SDS loading buffer. The samples were 
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separated by 16 % SDS-PAGE and dried. The dried gel was exposed to a 
phosphorimager screen (Amersham, Piscataway, NJ). Data was collected on a Typhoon 
9410 Variable Mode imager (Amersham, Piscataway, NJ) and analyzed using ImageJ.44 
 
2.5.4. CMeT crystallization 
 Protein stock solutions were dialyzed (4x, 1:2000) against crystallization buffer 
(25 mM Tris-HCl, 5 % (v/v) glycerol, 2 mM DTT, pH 7.0). All crystallization 
experiments were performed using a robotic setup applying the sitting drop vapor 
diffusion method. Crystals in space group H3 were grown at 17 °C by mixing 0.5 µL of 
protein at 14.9 mg/mL (supplemented with 2 mM SAH) in crystallization buffer with 0.5 
µL reservoir solution (0.1 M BIS-TRIS pH 6.57, 25% (w/v) PEG MME 2K) and grew to 
a final size of 0.4x0.2x0.1 mm3 within three days. Prior to harvesting, crystals were cryo-
protected by slowly exchanging the drop solution (0.1 M BIS-TRIS 8.0 pH, 25 % (w/v) 
PEG MME 2K, 10 mM acetoacetyl-CoA, 20 % (v/v) ethylene glycol) followed by an 
incubation of 5 min and flash freezing in N2(l). SeMet CMeT was crystallized in space 
group H3 at 17 °C by mixing 0.5 µL of protein at 14.3 mg/mL (supplemented with 2 mM 
SAH) in crystallization buffer with 0.5 µL reservoir solution (0.1 M BIS-TRIS pH 6.21, 
21.4% (w/v) PEG MME 2K). Crystals were harvested after four days at a size of 
0.4x0.3x0.05 mm3. Prior to harvesting and flash freezing in N2(l), crystals were 
dehydrated and cryo-protected (0.1 M BIS-TRIS pH 6.5, 30.0 % (w/v) PEG MME 2K, 2 
mM SAH, 25 % (v/v) ethylene glycol) by carefully exchanging the drop solution over a 
period of 30-60 min. 
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2.5.5. Data collection, structure determination and analysis 
 Data sets were collected at the Swiss Light Source (SLS, Villigen, Switzerland) at 
beamline X06DA (native: λ = 0.99998 Å and 1.90747 Å; SeMet: λ = 0.97929 Å) and a 
temperature of 100 K. Data reduction was performed using DIALS45 and XDS46, datasets 
were analyzed with Phenix47. Resolution cutoffs were determined by CC1/2 criterion.48 
The structure of SeMet CMeT was solved by SAD phasing using SHELX.49 The 
asymmetric unit contained one protomer, which was used for initial phasing of native 
crystals diffracting to higher resolution using molecular replacement in PHASER.50 
Initial maps were improved by density modification using PARROT51, followed by 
automated rebuilding with BUCCANEER.52 The final model was obtained after iterative 
cycles of model building in COOT53 and TLS refinement in Phenix47, yielding excellent 
geometry (Ramachandran favored/outliers: 99.48 % / 0.00 %) and Rwork/Rfree values of 
0.19 / 0.22 (Appendix A). The final model covers residues 1785-2163. All structures of 
native and SeMet-labeled protein revealed weak, but significant Fo-Fc difference density 
for a partially occupied ligand in the ligand binding tunnel (Appendix A), which could 
not be displaced by acetoacetyl-CoA soaks (cryo solutions + 15 mM acetoacetyl-CoA). 
Anomalous data collection at λ = 1.90747 Å did not reveal significant anomalous signal 
as expected for a fully occupied sulfur or phosphorus atom as part of the ligand 
(Appendix A). The observation was verified by two protein purifications and crystal 
treatments in the presence or absence of acetoacetyl-CoA. Despite the featured shape of 
the density, the nature and origin of the ligand, either from the crystallization conditions 
or protein purification, could not be unambiguously determined. 
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 Related folds were identified using the protein structure comparison service 
PDBeFold at European Bioinformatics Institute (http://www.ebi.ac.uk/msd-srv/ssm), 
authored by E. Krissinel and K. Henrick42, using 40 % (query) and 70 % (target) as 
matching parameters, and interfaces were analyzed using QtPISA.54 Bias-removal for Fo-
Fc omit maps was achieved by applying a random perturbation to coordinates (Δ0.2 Å) 
and B-factors (Δ20 % of the mean overall B-factor) using MOLEMAN255 prior to 
refinement. Figures were generated using PYMOL.56 
 
2.5.6. Phylogenetic sequence analysis 
 Fifty-one sequences of CMeT domains from NR-, HR-, cis-AT- and trans-AT 
PKS as well as FAS were selected to analyze phylogenetic distances. Sequences of 
inactive pseudo CMeT domains were included for FAS and HR-PKS. Alignments were 
generated using Clustal Omega57 and phylogenetic trees were generated using the 
neighbor joining algorithm implemented in Geneious version 8.1.6 
(http://www.geneious.com).58 
 
2.5.7 Accession Number 
 The atomic coordinates and structure factors have been deposited in the PDB 
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Chapter 3: Exploring fungal polyketide C-methylation through 
combinatorial domain swaps 
 
 
3.1.     Introduction 
 The adaptation of biological catalysts to perform desired reactions on synthetic 
scales – biocatalysis – has led to greener and more efficient chemical pathways, several 
of which are vital for pharmaceutical and industrial products.1 A typical biocatalyst is an 
enzyme or organism derived directly from a natural source and/or modified to better suit 
the intended application, maximizing properties such as stability, activity, and regio- or 
stereoselectivity. Mankind has employed biocatalysts since the dawn of agriculture 
through the use of native yeast strains to leaven bread and ferment wine, beer, and mead. 
While these techniques were improved empirically over the centuries, the modern field of 
biocatalysis began within the last century with the application of biological catalysts to 
specific chemical transformations, notably the production of stereopure mandelonitrile 
and hydroxylated steroids.1, 2 Since then, biocatalysis has been categorized into three 
“waves” that sequentially capture the technologies used to produce novel catalysts.1, 3, 4 
Briefly, the first wave includes catalysts that are used as found in nature or with minimal 
optimization, the second wave took advantage of early protein engineering techniques 
and rational mutagenesis from enzyme structures, and the third wave partnered directed 
evolution with high throughput analysis, returning to the empiricism found at the roots of 
biocatalysis. 
 A survey of the commercial biocatalysts highlights several common themes and 
suggests where future efforts might be directed. The most successful class of biocatalysts 
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has be the ketoreductases (KREDs), which have been used to stereospecifically reduce 
ketones in the production of pharmaceuticals including statins and antiretrovirals.1 
Transaminases, hydrolases, and oxidases have also served as commercially successful 
biocatalysts. Powerful and profitable as they have been, these enzymes share reactivity 
towards activated carbon centers or heteroatoms, but enzymes that catalyze C-C bond 
formation are noticeably rare despite the importance of such bonds and bond-forming 
reactions in synthetic organic chemistry. 
 Polyketide synthases (PKSs) have been long-standing targets for engineering 
biosynthetic pathways because of the inherent structural and stereochemical complexity 
built into their products.5 Like fatty acid synthases (FASs) and non-ribosomal peptide 
synthetases (NRPSs), PKSs tether growing intermediates to the enzyme by 
thioesterification to the phosphopantetheine arm of a carrier protein that delivers the 
intermediates to client domains for successive rounds of elongation and modification. 
FASs and PKSs share the core reaction – ketosynthase-catalyzed C-C bond formation by 
decarboxylative Claisen condensation, extending the intermediate by two carbons each 
cycle. However, PKSs occasionally implement a secondary C-C bond forming reaction 
through regiospecific α-methylation by an S-adenosylmethionine (SAM)-dependent C-
methyltransferase (CMeT), either free-standing or embedded in the PKS.  
 This second transformation includes several features that may be desireable for 
enzyme engineering and biocatalysis. First, the methyl acceptor substrates for PKS 
CMeTs are surprisingly varied. Bacterial Type II PKS natural products can be C-
methylated by stand-alone CMeTs following aromatization or cyclization, as in the 
geminal bismethylation seen in resistomycin and benastatin biosynthesis in 
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Streptomyces.6, 7 Type I highly-reducing PKSs (HR-PKSs) found in both marine 
cyanobacteria and fungi, modular and iterative systems respectively, can singly methylate 
polyene β-ketoacyl substrates as in curacin and lovastatin biosynthesis, through use of a 
PKS-embedded CMeT.8, 9 For both examples, multiple β-ketoacyl species of different 
chain length could be presented to the CMeT, but only a single regiospecific methylation 
is observed. Some fungal non-reducing PKSs (NR-PKSs) also contain embedded CMeT 
domains and are known to methylate linear substrates ranging from C4 to C14 prior to 
cyclization by the product template domain, with many of these CMeTs acting multiple 
times during iterative catalysis.10, 11 That such different acceptor substrates are tolerated 
across all PKS CMeTs may reflect an inherently pliable active site and substrate 
flexibility, amenable to engineering for biocatalysis. 
 Though structures of PKS CMeTs remain few in number compared to established 
families of biocatalysts, two features common to all CMeTs may be advantageous to 
future efforts to engineer general C-C bond forming biocatalysts. In Type I PKS CMeTs, 
there is a two subdomain architecture comprised of an N-terminal cap and C-terminal 
Rossmann fold, with the active site positioned in a cleft at their interface.9, 10 The 
presence of the N-terminal subdomain is a diagnostic indicator that the CMeT is active 
and not an evolutionary structural remnant, as in the Ψ-CMeT in mammalian FAS with 
only a vestigial helical bundle. The majority of small molecule methyltransferases 
(MTases) are Class I, or Rossmann fold-containing, and predominantly act on more 
nucleophilic O-, N-, or S-methyl acceptors and have little or no N-terminal subdomain.12, 
13 The CurJ and PksCT CMeT active sites are large and relatively hydrophobic, even 
though some methylated substrates are as small as acetoacetyl-ACP, though no acceptor 
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substrates have been observed in CMeT active sites, only the β-ketoacyl moiety appears 
to make specific contacts with binding pocket residues due to the lack of H-bond donors 
and acceptors other than the catalytic His-Glu dyad.10 Therefore, the N-terminal 
subdomain and large acceptor binding pockets of PKS CMeTs could be attributes for 
modulating selectivity or activity towards non-native substrates. 
 Finally, recent advances in synthetic SAM analogues has greatly expanded the 
repertoire of alkyl substituents that can be transferred by MTases and opened new 
avenues for C-C bond biocatalysis.14 Instead of a methyl group, these analogs contain n-
alkyl, allyl, azido, alkynyl, or benzyl groups at the sulfonium center.15, 16 Significant 
effort is still required to translate MTases into general alkylation biocatalysts, however.  
 While a free-standing, “plug-and-play” collection of CMeTs would be ideal, an 
ensemble of regiospecific CMeTs that could be added to an engineered polyketide 
biosynthetic pathway would also be useful. Previous work in the Townsend lab has 
leveraged the ability to deconstruct multienzymes into their constituent domains as a way 
to explore NR-PKS activity. Chain length, cyclization, and product release have been 
surveyed by domain deconstruction and combinatorial domain swap reactions in prior 
work.17-19 We sought to expand this approach to study fungal polyketide C-methylation. 
A deeper understanding of how fungal NR-PKS CMeTs act in a programmed fashion – to 
methylate only specific positions on the acceptor substrate during specific iterative cycles 
– might facilitate rational regiospecific methylation of engineered polyketides. Lessons 
learned through this endeavor will explore the “rules” of NR-PKS CMeTs and serve as 
guidelines for subsequent efforts to employ this highly specific family of alkylating 
enzymes and, hopefully, accelerate the development of C-C bond-forming biocatalysts. 
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3.2. Results and Discussion 
3.2.1. Preparation of Group VI and VII NR-PKS domain fragments 
 In order to build a domain library for combinatorial swap experiments, we 
surveyed the literature for fungal Group VI and Group VII NR-PKSs.11 Only those PKSs 
that had a known product associated with them were included, to allow for comparison of 
the native methylation pattern to the pattern seen with in vitro domain swap reactions. 
Several of the PKSs selected were only associated with immediate post-PKS products, 
while others are also associated with a final natural product. Finally, we omitted PKSs 
that utilized complex starter units derived from upstream HR-PKSs or FASs such as the 
asperfuranone PKSs AfoG and AfoE and the alkylisoquinoline synthase PkiA.11, 20 The 
candidates selected were PksCT (Monascus purpureus)21, MpaC (Penicillium 
brevicompactum)22, DtbA (Aspergillus niger)23, and PkeA, AusA,  and PkbA (A. 
nidulans).11 Each of these PKSs utilizes an acetyl starter unit, produces tetra- or 
pentaketides, and installs one to three C-methyl groups in the native product, and we 
reasoned that their similarity would maximize the chances for successful non-cognate 
interactions (Figure 3.1). 
 59 
 
Figure 3.1: Fungal NR-PKSs selected for domain deconstruction and combinatorial swaps. Group VI 
and VII NR-PKSs share a common domain architecture (top), with Group VI terminating in a TE domain 
to release the polyketide as the carboxylic acid and Group VII terminating in a R domain to give an 
aldehyde. Some PKSs, including DtbA, contain two ACP domains. The curated group of NR-PKSs is 
shown in boxes with the linear methylated intermediate shown on the left of the arrow and the released 
product on the right. (SAT: starter unit-ACP transacylase, KS: ketosynthase, MAT: malonyl-CoA:ACP 
transacylase, PT: product template, ACP: acyl carrier protein, CMeT: C-methyltransferase, R: reductase, 
TE: thioesterase). 
 Using the Udwary-Merski algorithm in combination with the early experience of 
dissecting PksCT domains (see Chapter 2)10, 24, we generated expression constructs for 
the SAT-KS-MAT tridomain, and CMeT and ACP mono-domains (Appendix B). These 
three would constitute the “minimal methylating PKS,” with all necessary domains to 
carry out multiple rounds of extension and methylation. Based on the initial PksCT 
results, we decided to omit PT and R or TE domains and relied on spontaneous 
intramolecular C-O cleavage of the holo-ACP thioester to release intermediates as 
pyrones, a commonly observed PKS derailment product. Test expressions showed that 
not all desired fragments expressed or were soluble, especially for the SAT-KS-MAT 
fragments; this outcome is consistent with previous attempts to express SAT-KS-MATs 
across multiple fungal NR-PKS Groups and did not improve when alternate cut sites 
were used (Table 3.1).19 
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NR-PKS SAT-KS-MAT ACP(n) CMeT 
PksCT Expression, soluble Expression, soluble Expression, soluble 
DtbA No expression Expression, soluble Expression, soluble 
MpaC No expression No expression No expression 
AusA No expression Expression, soluble Expression, soluble 
PkbA No expression No expression Expression, very 
unstable 
PkeA Expression, soluble Expression, soluble Expression, soluble 
Table 3.1: Domain deconstruction of Group VI & VII NR-PKSs. 
 Unfortunately, SAT-KS-MAT fragments for PkeA and PksCT were the only two 
available for experiments, despite several attempts to optimize cut-sites and expression 
conditions for the remaining SAT-KS-MAT fragments.  Another notable result of our 
domain deconstruction was the complete lack of soluble fragments from MpaC. We also 
found expressing fragments from PkbA challenging, but were able to generate small 
amounts of the CMeT monodomain. Overall, both ACP and CMeT monodomain 
fragments were generally well behaved for most of the PKSs in our library. The success 
rate of domain deconstruction highlights several bottlenecks to this approach, namely the 
necessary removal of introns from the expression sequence and the difficulty of 
heterologous expression for proteins of high molecular weight. While identifying 
incorrectly annotated exon boundaries can be done by mRNA sequencing if producing 
conditions in the native organism are known, we did not obtain experimental exon 
boundaries for cryptic PKSs activated by en masse promoter replacement strategies.11 In 
silico approaches like the exon predictor FGENESH can be useful if there is high 
confidence in a single alternate exon boundary, especially if it restores highly conserved 
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residues as in the case of PksCT. However, multiple predicted coding sequences can 
impose a significant obstacle to identifying the true coding sequence. 
3.2.2. In vitro CMeT domain swaps result in altered methylation patterns 
 From the soluble, expressed fragments we were able to conduct exploratory 
reactions to gauge the cross-compatibility of CMeTs with components from other NR-
PKSs. All apo-ACPs were activated using the promiscuous phosphopantetheinyl-
transferase Sfp from Bacillus subtilis to give holo-ACP.25 PKS domain fragments were 
incubated with acetyl-SNAC, malonyl-SNAC, and SAM, and reactions were extracted 
and analyzed by HPLC and UPLC-ESI-MS. Reconstitution of the minimal PksCT was 
discussed in detail in Chapter 2, and the minimal PkeA reaction demonstrated a similar 
outcome (Figure 3.2A). The major product was the unmethylated triketide 1, however the 
tetraketide 2 was also detected as a minor product. Thus, the spontaneous release of 
unmethylated intermediates – either from the holo-ACP thioester or the KS active site 
thioester – appears to be a general trend for CMeT-containing NR-PKSs. We speculate 
that tetraketide 2 may be favored in PkeA because the native substrate is only methylated 
once following the third extension (see Figure 3.1), so longer unmethylated substrates 
must be better tolerated for productive biosynthesis, compared to PksCT. Intramolecular 




Figure 3.2: Reconstitution of the “minimal PKS” for PksCT and PkeA and ACP swaps. A) HPLC 
traces respectively, monitored at 280 nm, for PksCT and PkeA minimal PKS reactions. While PksCT only 
produces the common PKS derailment product triketide 1, PkeA also produces a minor product tetraketide 
2, perhaps reflecting an inherent tolerance for unmethylated substrates seen in native PkeA biosynthesis. B) 
Non-cognate ACPs are competent but less active when paired with PksCT SAT-KS-MAT. C) Non-cognate 
ACPs are competent and somewhat more active when paired with PkeA SAT-KS-MAT, though the ratio of 
1 to 2 varies depending on the ACP. Traces are stacked vertically for clarity. See Appendix B for further 
characterization. 
 Subsequently, we swapped ACPs to these minimal PKS reactions to determine the 
compatability of non-cognate ACPs to participate in acyl substrate transfer and 
elongation (Figure 3.2B and C). As observed for non-methylating NR-PKSs, ACPs are 
generally interchangeable, though the yield or ratio of pyrone products depends on the 
identity of the ACP.19 While ACPs monodomains tend to be amenable to domain 
dissection, it is difficult to assess the degree to which it impacts synthesis in this case as 
the corresponding experiment with full-length PKSs remains out of reach. In non-
methylating NR-PKSs, dissection reduced yield by an order of magnitude, but the 
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differences in product profiles seen in the above ACP swaps are consistent with previous 
work.19 
 We then added CMeT monodomains to PksCT or PkeA minimal PKSs. 
Unfortunately, PkbA CMeT was particularly unstable, and after multiple attempts, could 
only be prepared for a single reaction with PksCT. From the observed pyrones, several 
aspects of C-methylation were evident. Non-cognate CMeTs generally are capable of 
intercepting acyl-holo-ACP species and dramatically reduce the yield of unmethylated 
polyketides. Because these pyrones have very similar UV-Vis absorption spectra, we 
assume peak areas can be roughly correlated. In PksCT-based reactions (Figure 3.3A), 
the triketides 3, 4, and 5 accumulate when non-cognate CMeTs are added and are 
significantly less abundant than 1 in the absence of a CMeT. The position of the methyl 
group for the singly methylated triketides 3 and 5 has been determined by comparison to 
an authentic standard of 5 (See Chapter 2 for detailed discussion of 3). 
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Figure 3.3: CMeT domain swaps result in differently methylated pyrone products. Addition of non-
cognate CMeTs to the PksCT (A) or PkeA (B) minimal PKS results in methylated pryrone product profiles 
that are CMeT-specific. See Appendix B for further characterization. 
 In PkeA-based reactions (Figure 3.3B), non-cognate CMeTs resulted in no 
observed product (AusA and DtbA), or an assortment of low-abundance methylated 
pyrones (PksCT). Notably, the addition of PkeA CMeT to the cognate PkeA SAT-KS-
MAT + ACP, increased the amounts of 1 and produced the singly methylated tetraketide 
6, consistent with the native PkeA methylation pattern. However, the methylated 
positions for tetraketides 6, 7, and 8 could not be unambiguously determined from 
fragmentation during mass spectrometry or comparison to standards. The two doubly 
methylated tetraketides indicate that PksCT CMeT occassionally skipped methylation 
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following at least one of the first three extension cycles. The KS domain of PksCT was 
previously shown to be sensitive to the absence of methylation on the growing 
intermediate (Chapter 2). Because the native product of PkeA is not methylated following 
the first two extensions, the KS may be sensitive to the presence of methylation on early 
stage intermediates. Without additional SAT-KS-MAT fragments to test, the generality of 
KS sensitivity to methylation remains unclear. 
 A second set of reactions was also carried out, analogous to those above, but the 
ACP and CMeT were cognate and paired with a non-cognate SAT-KS-MAT (Figure 3.4). 
 
Figure 3.4: Product profiles change slightly when the ACP is cognate to the CMeT. A) PksCT SAT-
KS-MAT or B) PkeA SAT-KS-MAT was added to cognate pairs of ACP and CMeT. Extension and 
methylation depend on binding acyl-ACP intermediates, and ACP identity may influence competiting rates. 
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In most reactions, the observed products were consistent whether the ACP was paired 
with the SAT-KS-MAT or CMeT, with some exceptions. Paired PkeA ACP and CMeT 
were less effective at producing methylated pyrones with PksCT SAT-KS-MAT than 
when the ACP was paired with the tridomain, perhaps because PkeA CMeT does not 
natively methylate early acyl intermediates, and spontaneous release at the triketide stage 
is faster than the methylation programmed by PkeA CMeT. When PkeA SAT-KS-MAT 
was used, ACP and CMeT pairs from DtbA and AusA were able to generate products, 
instead of completely stalling extension. PksCT ACP and CMeT were also able to 
generate the late-stage tetra- and pentaketide pyrones 9 and 10. 
 In total, this series of observations reflects the in trans nature of acyl-ACP species 
with both the CMeT and the other client domains, particularly the KS in domain-
dissected reconstitution reactions. The growing acyl intermediates must leave the KS 
active site, travel through solvent while bound to the ACP, and finally dock within the 
CMeT active site. That the CMeT lowers the rate of extension so significantly suggests 
that it competes with the KS for binding of acyl-ACP intermediates. In non-methylating 
NR-PKSs, extension is very rapid and the growing poly β-ketone intermediate likely 
remains shielded in the KS, as almost no products of intermediate chain length are 
detected.26 The addition of a CMeT obviously slows extension as the population of 
intermediate acyl-ACP species is now split among one additional competing binding 
partner. 
 The methylation program for each CMeT appears to be intrinsic, even in the 
context of domain dissection. The non-cognate CMeT tends to methylate substrates with 
less fidelity than cognate systems, but with a bias towards the native methylation pattern 
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of the CMeT. For example, most of the non-cognate CMeTs added to minimal PksCT did 
not completely eliminate production of the unmethylated triketide 1, even though the 
cognate PksCT CMeT completely eliminates this product (see Chapter 2). There remain 
significant gaps in rationalizing all aspects of the product profile. Without more domain 
fragments, especially SAT-KS-MATs, it is unclear how sensitive KS domains might be 
to alternate methylation patterns. The lack of improperly methylated intermediates in 
PksCT reconstitution suggests reasonably high fidelity to the “programmed” methylation, 
but not all reaction outcomes are equally informative. For example, if methylating 
acetoacetyl-ACP after the first Claisen condensation renders the intermediate an 
unfavorable substrate for continued cycles in PkeA, available free holo-ACP will 
decrease and such an intermediate is less susceptible to spontaneous release (no pyrone 
formation is possible before the triketide). Attempts to release small intermediates from 
the ACP by transthioesterification to cysteamine were unsuccessful.27 
 These experiments also lack the cyclization and release domains – PT and R or 
TE, respectively. Little is known about how these domains interact with their substrates 
and whether the correct methylation pattern is necessary for activity. Sensitivity of the 
KS and PT to the stereochemistry of methyl groups (before cyclization), is also unknown. 
Domain dissection certainly increases the likelihood of racemization of a given α-methyl 
position as the acyl-ACP docks to other domains in trans, a slower, solvent-exposed 
process. The interdependence of catalytic activity and substrate affinities in interative 
PKS domains stems from billions of years of co-evolution and will likely remain a 
fundamentally unresolved problem in the field until large numbers of multidomain 
structures are available, with multiple bound substrates. 
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3.2.3. Hypermethylation of linear substrates at high CMeT concentration 
 The molecular basis of programmed methylation patterns is still incomplete, but 
some attempts have been made to functionally account for how iterative catalysis 
operates. Studies on the fungal HR-PKS LovB, responsible for lovastatin biosynthesis, 
recently probed how acyl-ACP intermediates are appropriately directed towards the next 
catalytic domain in the programmed sequence.28 A diene triketide is α-methylated by a 
CMeT prior to ketoreductase (KR)-catalyzed reduction of the β-ketone to the 
corresponding alcohol. Because the α-position is most acidic at the β-keto thioester stage, 
and most available for methylation, the CMeT must act first. As in the NR-PKSs 
discussed above, LovB appears to be sensitive to substrates that are not methylated, as in 
the absence of SAM, intermediates are spontaneously released as penta-, hexa-, and 
heptaketide pyrones.8 By providing synthetic substrates that varied chain length and β-
functional groups, the authors were able to demonstrate that the CMeT has high catalytic 
efficiency towards only the on-path diene triketide, whereas the KR is less selective and 
less efficient. The proper order of methylation and reduction is functionally enforced by 
C-methylation being very fast for only a single intermediate while ketoreduction is 
slower but for a wider range of substrates, consistent with only a single methylation but 
multiple ketoreductions during synthesis of the LovB product. 
 We wanted to probe whether a similar process might be followed in methylating 
NR-PKSs, but by balancing rates of extension and methylation instead of methylation 
and reduction. A panel of specific synthetic intermediates could not be screened due to 
their inherent reactivity, so the relative amount of CMeT was varied to influence the 
overall rate of methylation (Figure 3.5). 
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Figure 3.5: Increasing relative amounts of CMeT results in hypermethylation of pentaketide 
intermediates.  PksCT SAT-KS-MAT and ACP (10 µM each) was incubated with increasing 
concentrations of PksCT CMeT, showing that with excess CMeT, non-native methylation of the final α-
position can occur giving the pentaketide 12. Traces are vertically stacked and the peak for 1 is truncated 
for clarity. See Appendix B for further characterization. 
When even very small amounts of CMeT were added to the reaction, the production of 
triketide 1 was dramatically reduced, and as the relative concentration of CMeT increased 
the total number of singly methylated pyrones 3, 5, and 11 increasd. At approximately 
equimolar CMeT, multiply methylated pyrones 4, 9, and 10 dominated the reaction 
profile, consistent with expected on-path intermediates. And with excess CMeT, a new 
pair of product peaks appeared, proposed to be the hypermethylated pentaketide 12. 
Because 12 elutes as two peaks with identical mass, fragmentation, and chromophores, 
just like on-path pentaketide 10, it is likely to retain the stereocenters that give rise to 
diastereomers – ruling out gem-dimethylation of a single position and therefore 
supporting non-native methylation following the final extension. 
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 We propose that the kinetic balance of extension and methylation determines the 
observed methylation pattern (Figure 3.6). Like the model described for LovB, different 
domains may have catalytic efficiency towards different substrates such that only the 
programmed outcome is kinetically favorable. At low concentrations of CMeT, not all 
programmed methylations can occur before the KS performs another extension 
generating an off-path intermediate. At high concentration, the selectivity against 
positions that are not part of the “methylation program” can be overcome by increasing 
the overall rate of methylation. These experiments cannot replicate the kinetic advantage 
found in an intact NR-PKS, where the effective concentrations of acyl-ACP and client 
domains are high. It is also possible that other conformational changes transmitted within 
an intact NR-PKS could be involved in control of methylation.  
 
Figure 3.6: Kinetic balance of methylation and extension. Following extension, the acyl-ACP 
intermediate is a potentially suitable substrate for both methylation and another round of extension. The 
relative rates of these competing reactions for the various ACP-bound intermediates present during iterative 
biosynthesis may dictate the “program.” 
 
3.3. Conclusions 
 The development of engineered biosynthetic pathways, and biological catalysts 
generally, would benefit from regiospecific or programmable C-C bond forming 
reactions. Fungal PKSs are a source of embedded CMeTs that perform such programmed 
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alkylations, and little is known about how this process in controlled. We assembled a 
small library of CMeTs and expanded an in vitro domain swap approach to explore the 
factors controlling polyketide C-methylation. We found that NR-PKS CMeTs were 
capable of methylating acyl-ACP intermediates in trans, and that the methylation 
program is intrinsic to the CMeT. The product profiles could be modulated based on the 
concentration of CMeT, even allowing for non-native methylation. Together the data 
suggest that part of methylation control is a kinetic balance between the rates of extension 
and methylation, though a molecular or structural basis for differential rates remains to be 
established. A more comprehensive collection of CMeT domains, development of 
chimeric intact NR-PKSs, and structures of multidomain PKS fragments with bound 
substrates can each offer additional information about methylation programming. 
 
3.4. Experimental 
3.4.1. Materials, strains, and genomic DNA purification 
 All reagents were purchased from Sigma Aldrich (St. Louis, MO) except 
AcSNAC, which was prepared synthetically, and MalSNAC, which was prepared 
enzymatically by MatB and purified.18, 19 Standard molecular biology procedures were 
used for isolation of DNA and the creation of expression plasmids. Sequencing was 
performed at the Johns Hopkins University Synthesis and Sequencing Facility 
(Baltimore, MD). M. purpureus NRRL 1596, Aspergillus niger NRRL 328, Aspergillus 
nidulans NRRL 194, and Penicillium brevicompactum NRRL 2011 were received from 
the ARS, USDA (Peoria, IL) and cultured on PDA plates. Collected mycelia were flash 
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frozen, ground under N2(l) and gDNA was purified using the DNeasy Plant Mini kit 
(Qiagen, Hilden, Germany). Overlap extension polymerase chain reaction using the 
primers listed in Appendix B was used to amplify exons and assemble intron-free 
expression inserts, which were ligated into pET-24a (Novagen) with a C-terminal His6 
tag. 
 
3.4.2. Preparation and expression of PKS domain fragments 
 Details of expression constructs and domain boundaries can be found in Appendix 
B. Plasmids were transformed to E. coli BL21(DE3) by electroporation and maintained 
on LB agar plates.  Expression cultures were grown in LB media at 37 °C to OD600 of 
0.6. Cultures were cold-shocked in an ice bath for about 1 h, and induced with 1 mM 
IPTG (GoldBio, St. Louis, MO) overnight at 18 °C, shaking at 225 rpm. Cell pellets were 
harvested by centrifugation for 15 min, at 4,000 x g, 4 °C and either flash frozen in N2(l) 
and stored at -80 °C until use, or resuspended immediately in 5 mL/g cell pellet in lysis 
buffer (50 mM potassium phosphate, 300 mM NaCl, 10 % glycerol, pH 7.6). 
Resuspended cells were lysed by sonication on ice for 10 x 10 s at 40% amplitude (Vibra-
Cell Ultrasonic Processor, Sonics & Materials, Inc., Newtown, CT). The lysate was 
cleared by centrifugation for 25 min at 27,000 x g, 4 °C and batch bound to Co2+-TALON 
(Clontech, Mountain View, CA) at 4 °C for 1 h. Expressed proteins were purified by 
gravity column chromatography as follows: the protein-bound resin was washed with 
lysis buffer (10 CV), followed by lysis buffer + 2 mM imidazole (5 CV) and elution with 
lysis buffer + 100 mM imidazole (5 CV). Domain fragments were dialyzed into reaction 
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buffer (100 mM potassium phosphate, 5 % glycerol, pH 7.0), concentrated by 
diafiltration, and used immediately or flash frozen in N2(l) and stored at -80 °C. 
 
3.4.3. In vitro domain swap reactions and analysis. 
Protein concentration was determined by Bradford assay (BioRad, Hercules, CA) in 
duplicate using bovine serum albumin as a standard.  Prior to in vitro reactions, ACPs (50 
µM) were activated by Sfp (1 µM) with CoASH (100 µM) and MgCl2 (10 mM) in 
reaction buffer for 1 h at room temperature as previously reported.19 Reconstitution 
reactions contained 10 µM of each included domain with 0.5 mM AcSNAC, 2 mM 
MalSNAC, 2 mM SAM, and 1 mM TCEP in reaction buffer totaling 250 µL. AcSNAC 
was prepared synthetically and MalSNAC was purified from MatB reactions.26 After 4 h 
at room temperature, the reactions were quenched with 5 µL concentrated HCl and 
extracted into ethyl acetate 3 x 250 µL. The combined organic extracts were dried to a 
residue and resuspended in 250 µL of 20 % aqueous acetonitrile. Extracts were analyzed 
on an Agilent 1200 HPLC with autosampler by injecting 100 µL onto a Prodigy ODS3 
column (4.5 x 250 mm, 5µ, Phenomenex, Torrence, CA) with 5-85 % MeCN/H2O, with 
0.1 % formic acid, over 40 min at 1 mL/min and monitored at 280 nm. Mass 
spectrometric analysis was done using a Waters Acquity Xevo G-2 UPLC-ESI-MS in 
positive ion mode, with 5 µL injected on a BEHC C18 column and 10-90 % MeCN/H2O, 
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Chapter 4: In trans hydrolysis of carrier protein-bound acyl 
intermediates by CitA during citrinin biosynthesis 
 
 
4.1.     Introduction 
 Polyketide synthases (PKSs) are multi-domain biosynthetic enzymes that catalyze 
the formation of complex carbon scaffolds through repeated rounds of extension and 
modification of simple acyl substrates.1-3 Intermediates are covalently tethered to the PKS 
by thioester linkage to a post-translationally installed phosphopantetheine arm of the acyl 
carrier protein (ACP) and delivered to the active sites of other domains for programmed 
chemistry.  Mature intermediates are released from the ACP through a number of 
mechanisms including hydrolysis, cyclization, and reduction, or transfered to a 
downstream carrier protein. The reactive nature of many PKS intermediates, however, 
occasionally results in the presence of acyl-holo-ACP species that are not on-path to the 
programmed PKS product and must be removed for productive chemistry to resume. This 
reactivity is fundamentally problematic for non-reduced polyketide intermediates that 
juxtapose nucleophilic and electrophilic moieties susceptible to intramolecular reactions 
that derail the acyl intermediate from the programmed path, for example, in the formation 
of the off-path SEK4 and SEK4b derailment products.4, 5 
 Ensuring that the genetic and metabolic investment in such large biosynthetic 
machinery is not perpetually waylaid, several different strategies to remove unproductive 
acyl intermediates have been employed across multiple types of PKSs. Many Type I 
PKSs have a thioesterase (TE) domain at their C-terminus commonly associated with 
product release, and some also have hydrolytic activity towards other acyl-holo-ACP 
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species.6 In some cases, however, this hydrolytic activity has been maintained by other 
proteins acting in trans. Fungal non-reducing PKSs (NR-PKSs) lacking a C-terminal TE 
domain can have a separate metallo-β-lactamase type TE in the same gene cluster that 
hydrolyzes the mature ACP-bound intermediate as in atrochrysone carboxylic acid 
biosynthesis.7 
 In bacterial trans-AT PKSs, PedC was recently shown to serve as a stand-alone 
acyl hydrolase (AH) capable of liberating several acyl species from the ACP in pederin 
biosynthesis.8 The presence of hydrolysis mechanisms across disparate PKSs suggests 
that this activity may represent a general strategy to maintain PKS efficiency in the 
absence of a cis-TE. 
 
Figure 4.1: Proposed role of CitA in citrinin biosynthesis. A) Domain architecture of PksCT, the fungal 
NR-PKS responsible for the first isolable intermediate in citrinin biosynthesis. The benzaldehyde 1 is 
subsequently reduced, cyclized, and oxidized by downstream enzymes CitB, CitC, CitD, and CitE to afford 
citrinin 2. B) CitA is proposed to intercept ACP-bound acyl intermediates in trans and catalyze hydrolysis 
to release free holo-ACP during stalled biosynthesis. (SAT: starter unit-ACP transacylase, KS: 
ketosynthase, MAT: malonyl-CoA:ACP transacylase, PT: product template, ACP: acyl carrier protein, 
CMeT: C-methyltransferase, R: reductase). 
 While many fungal NR-PKSs contain a C-terminal TE that may have an editing 
role, the recently categorized Group VII PKSs terminate instead with a reductase (R) 
domain that catalyzes NADPH-dependent release of the mature thioester intermediate as 
an aldehyde (Figure 4.1).9 Whether R domains are capable of carrying out an analogous 
editing function is unclear, but such a function would presumably involve the expenditure 
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of NADPH and be energetically expensive for the producing organism relative to 
hydrolysis. Additional work has identified the presence of a putative α/β-hydrolase-
encoding gene adjacent to Group VII PKSs in a number of biosynthetic gene clusters, and 
co-expression of the PKS and hydrolase gives greater titers of the post-PKS product 
compared to expression of the PKS alone.10, 11 Several roles for such putative hydrolases 
have been proposed, and this uncertainty was exacerbated by the initial misannotation of 
the start codon for these genes.12 While their exact function is not resolved, in trans 
editing of acyl intermediates is a possible role for these accessory proteins and one 
consistent with the in vivo results.  
4.2. Results 
4.2.1. In vitro reconstitution of PksCT with CitA 
 We sought to identify the activity of CitA (GenBank: BAE95339), the putative 
hydrolase adjacent to PksCT, the Group VII NR-PKS in the Monascus purpureus gene 
cluster responsible for citrinin biosynthesis.13, 14 Previously, CitA was re-annotated from 
an oxidoreductase to a hydrolase due to an incorrect initial assignment of the start codon, 
and deletion of CitA in the citrinin-producer Monascus ruber greatly decreased, but did 
not eliminate, production of the post-PKS aldehyde 1.10 Additionally, co-expression of 
both PksCT and CitA in the heterologous host Aspergillus oryzae gave significantly 
higher titers of 1 than the PKS alone. Based only on these observations, however, the role 
of CitA could not be established definitively. Using a previously reported domain-
deconstructed system, we added CitA to reconstituted PksCT in vitro to assess its effect 
on the characterized product profiles from specific domain combinations.15 Addition of 
CitA to all combinations of PksCT domains resulted in a concentration-dependent 
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decrease in the derailment products triketides 3 and 4, tetraketide 5, and pentaketide 6, as 
well as the on-path product aldehyde 1 (Figure 4.2). No new products were found as 
might be expected if CitA catalyzed a modification of PKS-bound intermediates or the 
final product 1. Unlike reported results of in vivo coexpression of PksCT with CitA, we 
did not observe any increase in 1 at any concentration of CitA. We suspect that synthetic 
inefficiencies from domain dissection may explain the lack of increase in 1 in vitro. The 
in vivo use of intact PksCT allows for intramolecular interaction between the ACP and 
other PksCT domains; however, we could not obtain soluble intact PksCT from 
heterologous expression in Escherichia coli or Saccharomyces cerevisiae to test this 
hypothesis. 
 
Figure 4.2: In vitro reconstitution of PksCT with CitA reduces product yield. A) Increasing 
concentration of CitA resulted in a corresponding decrease in the amount of all products for all tested 
domain combinations. Absorbance traces are vertically offset and shown at 280 nm; the bar to the left of 
each set of traces represents 10 mAu.  For a detailed discussion of these derailment products, see Chapter 2. 
B) Structures of PksCT derailment products detected in partial PksCT reconstitution reactions. 
4.2.2. CitA hydrolyzes acyl species from PksCT holo-ACP 
 Since CitA only appeared to decrease product yields, we speculated that it might 
be hydrolyzing one or more intermediates, analogous to a recent observation of in trans 
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acyl-holo-ACP hydrolysis in pederin biosynthesis.8 We identified a GxSxG active site 
motif common to α/β-hydrolases that was conserved in several putative CitA-like 
hydrolases adjacent to Group VII NR-PKSs, including AfoE, PkdA, PkeA, and PkhA 
(Figure 4.3).9, 16, 17 We also generated a homology model of CitA using the CPHmodels 
3.2 server, which identified the yeast serine hydrolase FSH1/YHR049W as the closest 
homolog of known structure (PDB: 1YCD).18, 19 The homology model suggested a 
Ser122-His235-Asp207 catalytic triad, consistent with recent in vivo observations of the 
CitA homolog MppD in azaphilone biosynthesis in M. purpureus.11  
 
Figure 4.3: Alignment of CitA to putative hydrolases adjacent to Group VII NR-PKSs. Eight Group 
VII NR-PKSs with known products were found to have a putative hydrolase gene adjacent to the PKS. 
Alignment of the hydrolase sequences identified a strongly conserved active site motif around Ser122. We 
also identified two conserved basic residues – Arg36 and Arg 236 – located near the active site entrance, 
based on homology modeling (discussed below). The alignment was done using ClustalX v2.1.20 
 To test CitA hydrolysis against the simplest of acyl-ACP species, PksCT apo-
ACP (ACPCT) monodomain was activated by the promiscuous phosphopantetheinyl-
transferase Sfp with [1-14C]-acetyl-CoA to give the radiolabeled acetyl-holo-ACPCT and 
incubated with CitA or CitA-S122A. Following separation of the reaction products by 
SDS-PAGE, we observed that the acetyl radiolabel was lost from ACPCT in a CitA-
dependent fashion, but CitA-S122A was inert (Figure 4.4).  A radiolabeled band 
consistent with the larger CitA was not detected in the gel, suggesting that CitA does not 
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retain the acetyl species for transfer to a downstream acceptor but rapidly hydrolyzes it to 
free acetate. 
 
Figure 4.4: CitA hydrolyzes acetyl-holo-ACP to free holo-ACP and acetate. Radiolabeled [1-14C]-
acetyl-holo-ACP was incubated with increasing concentrations of CitA or the putative active site mutant 
CitA-S122A. CitA removed the radiolabel in a concentration-dependent fashion, but CitA-S122A was 
inert. No corresponding transfer of the radiolabel to CitA was detected, suggesting it is not involved in acyl 
transfer. 
 Previous examples of editing TEs or hydrolases in PKS biosynthesis have been 
shown to have varying degrees of substrate promiscuity towards both on-path and likely 
off-path intermediates.6, 8 Many of the acyl-ACPCT intermediates en route to 1 are not 
accessible due to their inherent reactivity, preventing analysis of late-stage tri-, tetra-, or 
pentaketide intermediates. However, we tested the hydrolytic activity of CitA against 
malonyl-holo-ACPCT and acetoacetyl-holo-ACPCT – acyl species bound to ACPCT at 
early stages of the biosynthetic cycle. The mass of the acyl-ACPs was determined by 
UPLC-ESI-MS before and after incubation with CitA (Figure 4.5 and Appendix C). apo-
ACPCT was observed as a quartet of masses consistent with oxidation, acetylation, and 
both modifications that was also observed in every ACPCT species throughout these 
experiments.21 Loss of mass consistent with acyl hydrolysis was observed for both 
malonyl and acetoacetyl substrates when incubated with CitA. 
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Figure 4.5: Cit A hydrolyzes malonyl and acetoacetyl intermediates from holo-ACPCT. ACPCT was 
activated by Sfp to give Mal-holo-ACPCT (left, 15654 Da) or Acac-holo-ACPCT (right, 15652 Da) and then 
incubated with CitA for 30 min. UPLC-ESI-MS analysis showed masses consistent with the loss of each 
acyl species to give free holo-ACPCT (15568 Da). The ACP purifies as a mixture of four species: 
unmodified, oxidized [+16 Da], acetylated [+42 Da], and both [+58 Da], and these species are indicated by 
the horizontal bars extending from the unmodified mass (dashed vertical lines). 
Competition experiments combining malonyl- and acetoacetyl-holo-ACPCT did not show 
a significant substrate preference by CitA (See Appendix C). Attempts to obtain 
Michaelis-Menten values to compare these acyl species using the N-acetylcysteamine 
(SNAC) or CoA thioesters as substrate mimics were unsuccessful due to an inability to 
saturate CitA activity (Figure 4.6). The weak activity against small molecule substrates 
suggested that the ACP is an essential component of CitA substrates, focusing CitA 
activity towards PKS-bound intermediates and limiting indiscriminant hydrolysis of acyl-
CoA species. 
 
Figure 4.6: Example Michaelis-Menten kinetics of hydrolysis by CitA. Using Ellman’s reagent to detect 
and quantify release of free thiol following AcSNAC or AcCoA hydrolysis, CitA activity could not be 
saturated, even at high substrate concentrations. 
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4.2.3. Identifying key in trans interactions between PksCT ACP and CitA 
 Several investigations into the interactions of ACP domains with PKS or fatty 
acid synthase client domains, including product template, ketosynthase, and 
acyltransferase domains, have identified conserved basic residues that form contacts with 
the phosphodiester moiety of the phosphopantetheine arm or conserved acidic residues on 
the acyl-holo-ACP.22-26 Using our homology model in conjunction with sequence 
alignments of CitA to related hydrolases, we identified two basic residues – Arg36 and 
Arg236 – near the entrance of the CitA active site that could be involved in the 
CitA:ACPCT binding interface (Figure 4.7). Both are predicted to be within ~20 Å of 
Ser122, approximately the length of the extended phosphopantetheine arm, placing them 
in close proximity to negatively charged residues on the ACP surface.  
 
 
Figure 4.7: Homology model of CitA. The conserved active site His-Ser-Asp triad is shown in magenta. 
Two conserved basic residues, Arg36 and Arg236, are within ~20 Å of Ser122 which is the approximate 
length of the phosphopantetheine arm. For details on building the homology model, see 4.5 Experimental 
and Appendix C.  
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 CitA-R36A and CitA-R236A mutants were generated and incubated with [1-14C]-
acetyl-holo-ACPCT in a time-course assay and separated by SDS-PAGE (Figure 4.8). 
CitA-R236A was indistinguishable from the wild type and both completely hydrolyzed 
the acetyl radiolabel. In contrast, CitA-R36A had minimal hydrolytic activity suggesting 
that Arg36 has an essential role in mediating the in trans interaction between acyl-holo-
ACPCT and CitA. The conserved nature of this basic residue among CitA homologs in 
other fungal NR-PKS biosynthetic gene clusters reinforces the conclusion that CitA-like 
hydrolases preferentially act upon PKS-bound acyl intermediates. 
 
Figure 4.8: The CitA:ACP interface. Time-course incubation of CitA (1 µM) with [1-14C]-acetyl-holo-
ACPCT (10 µM) shows significantly reduced hydrolysis by the R36A mutant compared to wild type. The 
R236A mutation had minimal effect on CitA hydrolysis. 
4.3. Discussion 
 Unlike the clean linearity shown in textbook descriptions of biosynthetic 
pathways, production of secondary metabolites is subject to multiple competing 
processes. Deciphering contributions of both on- and off-path reactions can be 
particularly difficult for PKSs (as well as fatty acid synthases and non-ribosomal peptide 
synthetases) because intermediates are covalently tethered to the phosphopantetheine 
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arm. Premature hydrolysis of the labile thioester is a general off-path process, as is 
improper ordering of β-tailoring steps like reduction or dehydration with the next round 
of extension. A final common competing process in PKSs is spontaneous decarboxylation 
of an enzyme-bound malonyl unit to give a non-productive acetyl unit. Because multi-
domain structural information for PKSs with bound intermediates is only just becoming 
available, very little is known about the changes that can occur due to these off-path 
processes and how they are detected and resolved. 
 The observed in trans hydrolytic activity of CitA exemplifies two aspects of 
polyketide biosynthesis that converge to restore PKS activity and have become more 
widely appreciated in recent years: in trans domain:domain interactions and editing of 
non-productive intermediates. Early studies on modular PKSs supported an assembly-line 
model of biosynthesis where each module extended and modified the tethered substrate.27 
As genomic sequencing efforts accumulated thousands of uncharacterized biosynthetic 
gene clusters, increasingly diverse variations of this model were identified. A significant 
number of bacterial PKSs adopt a semi-modular architecture, where extension and 
tailoring steps are encoded within the domains of the module, but the extender units 
(malonyl or methylmalonyl) are loaded onto ACPs by a free-standing acyltransferase 
domain or trans-AT.28 The same trans-AT typically serves each module in the PKS. 
Fungal PKSs have also been shown to have trans-acting domains, notably LovC, a trans 
enoylreductase (ER) in lovastatin biosynthesis which substitutes for an inactive cis-ER in 
the highly-reducing PKS.29 Finally, thioesterase function in Group V NR-PKSs, which 
lack a C-terminal TE, has been maintained in trans by β-metallolactamase-like proteins. 
It remains unclear why trans-acting domains are used in some biosynthetic pathways but 
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not others. However, a genetic duplication resulting in a separate trans domain could 
allow for mutations to alter the function of the new monodomain. 
 Editing of PKS-bound intermediates is also a deviation from classical co-linearity 
seen in early PKS research. Like with trans-acting domains, examples of editing by 
hydrolysis of acyl intermediates are found in both bacterial and fungal PKSs. The TE 
domain from PksA in Aspergillus parasiticus was shown to hydrolyze acetyl and 
hexanoyl, but not malonyl, substrates.6 Since then, a surprising breadth of activities has 
been observed in fungal NR-PKS TEs, including deacetylation30 and enol lactonization31, 
but the generality of editing activity among cis-TEs is not known. The closest comparison 
to CitA, however, was recently found in bacterial trans-AT PKSs during pederin 
biosynthesis.8 Identified as an acyl hydrolase (AH), the investigators found that PedC, a 
protein encoded in the pederin cluster homologous to the trans-AT PedD, was active 
against a number of acyl-ACP substrates, particularly short chain acetyl and butanoyl 
thioesters. 
 Therefore, we propose that CitA serves a role at the confluence of these 
biosynthetic strategies. We suspect that the intramolecular relationship between acyl-
ACP intermediates and client domains favors on-path biosynthesis, but when derailment 
occurs (e.g. non-productive decarboxylation of malonyl-ACP) and the PKS stalls, CitA 
can intercept and clear the ACP-bound acyl species (Figure 4.9). The relative promiscuity 
of CitA towards ACP-bound acyl substrates can be rationalized in two ways. First, 
several off-path events could occur that result in stalled PksCT, including the 
aforementioned decarboxylation of malonyl-ACP, loss of KS-bound acyl intermediates 
with malonyl-ACP unable to complete extension, or insufficient levels of SAM to 
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methylate the acetoacetyl-ACP intermediate. Longer chain length intermediates may also 
be substrates for CitA but could not be assayed experimentally because spontaneous 
intramolecular C-O cleavage to the corresponding pyrone prohibits loading them onto an 
ACP, or even synthesizing them. Secondly, by strongly preferring ACP-bound 
intermediates, futile hydrolysis of small molecule acyl thioesters (e.g. AcCoA) is 
disfavored. It is still unknown how specific CitA-like editing hydrolases are towards their 
native PKS, and follow-up experiments pairing Group VII NR-PKSs with non-cognate 
hydrolases (including distant relatives such as PedC). 
 
Figure 4.9: CitA intercepts stalled PksCT and restores production by clearing acyl-ACP species. 
Through a number of spontaneous processes, the PKS can become stalled by having an ACP-bound acyl 
group that cannot participate in on-path biosynthesis. By removing the blocking acyl group, CitA frees 
PksCT to resume production of the aldehyde 1. 
 Additionally, the convergence of in vivo and in vitro results remains a priority. 
While an editing role is consistent with the in vivo co-expression of PksCT and CitA 
giving an approximately 20-fold increase in the product aldehyde 1, it was surprising to 
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find no increase in vitro.10 Some possible explanations are discussed above, but a more 
thorough answer will require use of an intact, full-length PksCT. Unfortunately, 
expression of full-length fungal PKSs for in vitro analysis remains beyond reach. We 
envision in trans editing hydrolases as a potential tool for improving engineered 
biosynthetic pathways, and any utility would benefit from a deeper understanding of the 
interactions between these hydrolases and the PKSs they interact with. 
4.4. Conclusions 
 In conclusion, our results expand the scope of in trans editing of acyl-ACP 
intermediates in fungi, and highlight it as a generalized strategy to ensure efficient 
polyketide biosynthesis, especially when the PKS lacks other self-editing mechanisms. 
We show that several carrier protein-bound acyl intermediates are removed by CitA and 
identify conserved features that are essential to CitA:ACP binding and hydrolysis. While 
acetyl-holo-ACPCT is an on-path intermediate to initiate citrinin biosynthesis, hydrolysis 
of acetyl-holo-ACPCT by CitA prevents stalling of PksCT in the event of spontaneous, 
non-productive decarboxylation of malonyl-holo-ACPCT during extension of longer 
chain-length intermediates. Additionally, hydrolytic activity towards malonyl or 
acetoacetyl intermediates may be necessary when other client domains like the 
ketosynthase, C-methyltransferase, or reductase have lost their bound co-substrates or 
have been otherwise inactivated. It remains unclear how PksCT and CitA collaborate in 
producing organisms, as the in vitro data do not replicate the increased yield seen in vivo. 
Acyl-holo-ACPCT species may be less exposed in intact PksCT than in our dissected 
system due to faster intramolecular shuttling of ACP-bound intermediates, favoring 
binding of ACPCT to other PksCT client domains relative to intermolecular association 
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with CitA. When PksCT is dissected, all ACPCT interactions occur in trans, with 
hydrolysis by CitA expectedly competing against polyketide synthesis. Further study of 
relative expression, catalytic rates, precursor availability, and other factors affecting 
efficiency may uncover the optimal balance between editing and productive biosynthesis. 
As a significant number of fungal and bacterial PKSs have been found to adopt in trans 
editing mechanisms, future work to engineer these polyketide pathways, or any others 
lacking metabolically optimized editing, may benefit by including an in trans hydrolase, 
perhaps under distinct and tunable control. 
 
4.5. Experimental 
4.5.1. Materials and Cloning 
All reagents were purchased from Sigma-Aldrich unless described otherwise. 
Commercially obtained malonyl-CoA and acetoacetyl-CoA were re-purified to minimize 
free CoA and acetyl-CoA. Purification was performed on an Agilent 1100 HPLC using a 
Phenomenex Kinetex C18 column (5 µm, 250 x 10 mm) with 100% H2O + 0.1% TFA for 
2 min followed by 0-35% MeCN/H2O + 0.1% TFA over 23 min at 4 mL/min. Purified 
CoAs were lyophilized and stored at -80 °C. [1-14C]-acetyl-CoA was purchased from 
Perkin Elmer and used without further purification. M. purpureus NRRL 1596 was 
obtained from the Agricultural Research Service, USDA. Mycelia were cultured on PDA 
plates and gDNA was purified using the DNeasy Plant mini Kit (Qiagen). The coding 
sequence for CitA was amplified from purified gDNA using primers MpOrf4-g5 and 
MpOrf4-g3 and Phusion polymerase (New England Biolabs) and ligated into pCR-Blunt 
vector using the Zero Blunt PCR Cloning Kit (Invitrogen). An expression insert 
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reflecting the re-annotated start codon was amplified from this plasmid using primers 
MpOrf4-5.2 and MpOrf4-3 and Phusion polymerase. The insert and pET-24a (Novagen) 
were digested with NdeI and NotI-HF (New England Biolabs) and ligated with T4 ligase 
(New England Biolabs). CitA mutant expression plasmids were prepared analogously to 
the wild-type plasmid by overlap extension PCR using the corresponding primers in 
Appendix C. Expression plasmid sequences were verified at the Johns Hopkins 
University Synthesis and Sequencing Facility. 
4.5.2. In vitro reconstitution of CitA with PksCT 
 A detailed description of PksCT reconstitution reactions and reaction products 
was previously published.15 Briefly, PksCT mono- and multidomain expression plasmids 
and CitA or CitA mutant expression plasmids were transformed into E. coli BL21(DE3). 
Expression cultures were grown at 37 °C in LB medium to OD600 of ~0.6, cooled in an 
ice bath, and induced with IPTG (1 mM, GoldBio) at 18 °C. Following overnight 
expression, cells were harvested by centrifugation at 4000 x g and flash frozen in liquid 
nitrogen for storage at -80 °C or resuspended in 5 mL/g lysis buffer (50 mM K/PO4, 300 
mM NaCl, 10% glycerol, pH 7.5) for immediate purification. The resuspended slurries 
were sonicated for 10 x 10 s, 40% amplitude (Vibra-Cell Ultrasonic Processor), on ice 
and cleared by centrifugation at 25,000 x g, 4 °C for 25 min. Lysates were batch bound to 
Co2+-TALON (Clontech) for 1 h, 4 °C and purified by gravity column, washing with 10 
column volumes of lysis buffer and 5 column volumes of lysis buffer + 2 mM imidazole, 
and eluted with 3 column volumes of lysis buffer + 100 mM imidazole. Purified proteins 
were dialyzed against reaction buffer (100 mM K/PO4, 5% glycerol, pH 7.0) flash frozen 
in liquid nitrogen, and stored at -80 °C until use. Protein concentrations were determined 
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using the Bradford Assay (Bio-Rad) in duplicate, with bovine serum albumin as a 
standard. ACPCT was activated by Sfp with CoASH and MgCl2. Reconstitution reactions 
included the listed PksCT domains at 10 µM each, with increasing concentration of CitA 
or CitA-S122A, along with 0.5 mM AcSNAC, 2 mM MalSNAC, 2 mM SAM, 1 mM 
NADPH, and 1 mM TCEP in reaction buffer to 250 µL. Reactions were run for 4 h at 25 
°C before being acidified with 5 µL concentrated HCl, extracted into ethyl acetate 3 x 
250 µL, and dried. The residue was dissolved in 250 µL 20% ACN/H2O and analyzed on 
an Agilent 1200 HPLC using a Phenomenex Prodigy ODS3 column (5 µm, 4.5 x 250 
mm) with 5-85% MeCN/H2O + 0.1% formic acid for 40 min at 1 mL/min. Products were 
detected by diode array at 280 nm. 
4.5.3. Radiolabel and LCMS assays of CitA activity 
 For radiochemical assays, purified apo-ACPCT (50 µM) was activated with [1-
14C]-acetyl-CoA (100 µM) by Sfp (1 µM) in dialysis buffer supplemented with MgCl2 
(10 mM) for 1.5 h at room temperature. As shown in Figure 4.4, radiolabeled acetyl-holo-
ACPCT (10 µM) was incubated with CitA or CitA-S122A (10, 1, 0.1, or 0.01 µM) in 
reaction buffer (50 µL total) for 5 min at 25 °C. As shown in Figure 4.8, radiolabeled 
acetyl-holo-ACPCT (10 µM) was incubated with CitA, CitA-R36A, or CitA-R236A (1 
µM), with aliquots taken at the given time-points. Reactions were quenched with 5X SDS 
loading buffer (lacking β-mercaptoethanol) and separated by SDS-PAGE (16%). Gels 
were dried, exposed to a phosphorimager screen overnight, and scanned on a Typhoon 
9410 Variable Mode Imager (Amersham Biosciences). Data were processed and analyzed 
using ImageJ.32 For LCMS assays, apo-ACPCT (100 µM) was activated with malonyl-
CoA or acetoacetyl-CoA (200 µM) by Sfp (1 µM) in reaction buffer supplemented with 
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MgCl2 (10 mM) for 2 h at room temperature. Acyl-holo-ACPCT (50 µM) was incubated 
with CitA (1 µM) for 30 min at 25 °C, and 2.5 µL were diluted to 200 µL with 20 % 
MeCN/H2O. The reactions were analyzed on a Waters ACQUITY Xevo G-2 UPLC-ESI-
MS in positive ion mode by injecting 5 µL onto a BEH C4 column with 100% H2O + 
0.1% formic acid for 1 min followed by 0-80% MeCN/H2O + 0.1% formic acid over 6.5 
min. ACPCT eluted at 6 min and detected ions at 600-2200 m/z were analyzed in 
MassLynx using MaxEnt deconvolution to give intact protein masses. 
4.5.4. Kinetics experiments with CitA and small molecule substrate mimics 
 Crystalline AcSNAC or HPLC purified AcCoA were dissolved in dialysis buffer 
to the desired stock concentration. CitA (1 µM) was preincubated with Ellman’s reagent 
(5,5’-dithiobis-(2-nitrobenzoic acid), 0.2 mM) at 25 °C for 2 min. Absorbance at 412 nm 
was monitored using a Cary UV/Vis spectrophotometer upon addition of small molecule 
substrate at 3 s intervals for 3 min at 25 °C. Absorbance data were analyzed in Prism 7 
and fit using a linear regression for the first 15 s of collected data. 
4.5.5. CitA homology model 
 The amino acid sequence for CitA was submitted to the CPHmodel server v3.2 
and a model was built from PDB: 1YCD with a Z-score of 30.4. The homology model 
was submitted to the RAMPAGE server and contained five residues in outlier regions, 
three on the boundary of allowed conformations and two residues on loops distant from 





1. Staunton, J.; Weissman, K. J., Polyketide biosynthesis: a millennium review. 
Natural Product Reports 2001, 18 (4), 380-416. 
2. Crawford, J. M.; Townsend, C. A., New insights into the formation of fungal 
aromatic polyketides. Nat. Rev. Microbiol. 2010, 8 (12), 879-89. 
3. Hertweck, C., The biosynthetic logic of polyketide diversity. Angew. Chem. Int. 
Ed. Engl. 2009, 48 (26), 4688-716. 
4. Newman, A. G.; Vagstad, A. L.; Storm, P. A.; Townsend, C. A., Systematic 
domain swaps of iterative, nonreducing polyketide synthases provide a mechanistic 
understanding and rationale for catalytic reprogramming. J. Am. Chem. Soc. 2014, 136 
(20), 7348-62. 
5. Fu, H.; Hopwood, D. A.; Khosla, C., Engineered biosynthesis of novel 
polyketides: evidence for temporal, but not regiospecific, control of cyclization of an 
aromatic polyketide precursor. Chem. Biol. 1994, 1 (4), 205-10. 
6. Vagstad, A. L.; Bumpus, S. B.; Belecki, K.; Kelleher, N. L.; Townsend, C. A., 
Interrogation of global active site occupancy of a fungal iterative polyketide synthase 
reveals strategies for maintaining biosynthetic fidelity. J. Am. Chem. Soc. 2012, 134 (15), 
6865-77. 
7. Awakawa, T.; Yokota, K.; Funa, N.; Doi, F.; Mori, N.; Watanabe, H.; Horinouchi, 
S., Physically discrete beta-lactamase-type thioesterase catalyzes product release in 
atrochrysone synthesis by iterative type I polyketide synthase. Chem. Biol. 2009, 16 (6), 
613-23. 
8. Jenner, M.; Afonso, J. P.; Kohlhaas, C.; Karbaum, P.; Frank, S.; Piel, J.; Oldham, 
N. J., Acyl hydrolases from trans-AT polyketide synthases target acetyl units on acyl 
carrier proteins. Chem Commun (Camb) 2016, 52 (30), 5262-5. 
9. Ahuja, M.; Chiang, Y. M.; Chang, S. L.; Praseuth, M. B.; Entwistle, R.; Sanchez, 
J. F.; Lo, H. C.; Yeh, H. H.; Oakley, B. R.; Wang, C. C., Illuminating the diversity of 
aromatic polyketide synthases in Aspergillus nidulans. J. Am. Chem. Soc. 2012, 134 (19), 
8212-21. 
10. He, Y.; Cox, R. J., The molecular steps of citrinin biosynthesis in fungi. Chem. 
Sci. 2016, 7 (3), 2119-2127. 
11. Balakrishnan, B.; Chandran, R.; Park, S. H.; Kwon, H. J., A New Protein Factor 
in the Product Formation of Non-Reducing Fungal Polyketide Synthase with a C-
Terminus Reductive Domain. J. Microbiol. Biotechnol. 2015, 25 (10), 1648-52. 
12. Davison, J.; al Fahad, A.; Cai, M.; Song, Z.; Yehia, S. Y.; Lazarus, C. M.; Bailey, 
A. M.; Simpson, T. J.; Cox, R. J., Genetic, molecular, and biochemical basis of fungal 
tropolone biosynthesis. Proc Natl Acad Sci U S A 2012, 109 (20), 7642-7. 
13. Shimizu, T.; Kinoshita, H.; Ishihara, S.; Sakai, K.; Nagai, S.; Nihira, T., 
Polyketide synthase gene responsible for citrinin biosynthesis in Monascus purpureus. 
Appl. Environ. Microbiol. 2005, 71 (7), 3453-7. 
14. Shimizu, T.; Kinoshita, H.; Nihira, T., Identification and in vivo functional 
analysis by gene disruption of ctnA, an activator gene involved in citrinin biosynthesis in 
Monascus purpureus. Appl. Environ. Microbiol. 2007, 73 (16), 5097-103. 
 94 
15. Storm, P. A.; Herbst, D. A.; Maier, T.; Townsend, C. A., Functional and 
Structural Analysis of Programmed C-Methylation in the Biosynthesis of the Fungal 
Polyketide Citrinin. Cell Chem Biol 2017, 24 (3), 316-325. 
16. Chiang, Y. M.; Szewczyk, E.; Davidson, A. D.; Keller, N.; Oakley, B. R.; Wang, 
C. C., A gene cluster containing two fungal polyketide synthases encodes the 
biosynthetic pathway for a polyketide, asperfuranone, in Aspergillus nidulans. J. Am. 
Chem. Soc. 2009, 131 (8), 2965-70. 
17. Brenner, S., The molecular evolution of genes and proteins: a tale of two serines. 
Nature 1988, 334 (6182), 528-30. 
18. Nielsen, M.; Lundegaard, C.; Lund, O.; Petersen, T. N., CPHmodels-3.0--remote 
homology modeling using structure-guided sequence profiles. Nucleic Acids Res. 2010, 
38 (Web Server issue), W576-81. 
19. Quevillon-Cheruel, S.; Leulliot, N.; Graille, M.; Hervouet, N.; Coste, F.; 
Benedetti, H.; Zelwer, C.; Janin, J.; Van Tilbeurgh, H., Crystal structure of yeast 
YHR049W/FSH1, a member of the serine hydrolase family. Protein Sci. 2005, 14 (5), 
1350-6. 
20. Larkin, M. A.; Blackshields, G.; Brown, N. P.; Chenna, R.; McGettigan, P. A.; 
McWilliam, H.; Valentin, F.; Wallace, I. M.; Wilm, A.; Lopez, R.; Thompson, J. D.; 
Gibson, T. J.; Higgins, D. G., Clustal W and Clustal X version 2.0. Bioinformatics 2007, 
23 (21), 2947-8. 
21. Zhang, J.; Sprung, R.; Pei, J.; Tan, X.; Kim, S.; Zhu, H.; Liu, C. F.; Grishin, N. 
V.; Zhao, Y., Lysine acetylation is a highly abundant and evolutionarily conserved 
modification in Escherichia coli. Mol. Cell. Proteomics 2009, 8 (2), 215-25. 
22. Weissman, K. J.; Muller, R., Protein-protein interactions in multienzyme 
megasynthetases. ChemBioChem 2008, 9 (6), 826-48. 
23. Barajas, J. F.; Shakya, G.; Moreno, G.; Rivera, H., Jr.; Jackson, D. R.; Topper, C. 
L.; Vagstad, A. L.; La Clair, J. J.; Townsend, C. A.; Burkart, M. D.; Tsai, S. C., 
Polyketide mimetics yield structural and mechanistic insights into product template 
domain function in nonreducing polyketide synthases. Proc Natl Acad Sci U S A 2017, 
114 (21), E4142-E4148. 
24. Miyanaga, A.; Iwasawa, S.; Shinohara, Y.; Kudo, F.; Eguchi, T., Structure-based 
analysis of the molecular interactions between acyltransferase and acyl carrier protein in 
vicenistatin biosynthesis. Proc Natl Acad Sci U S A 2016, 113 (7), 1802-7. 
25. Nguyen, C.; Haushalter, R. W.; Lee, D. J.; Markwick, P. R.; Bruegger, J.; 
Caldara-Festin, G.; Finzel, K.; Jackson, D. R.; Ishikawa, F.; O'Dowd, B.; McCammon, J. 
A.; Opella, S. J.; Tsai, S. C.; Burkart, M. D., Trapping the dynamic acyl carrier protein in 
fatty acid biosynthesis. Nature 2014, 505 (7483), 427-31. 
26. Bruegger, J.; Haushalter, R. W.; Vagstad, A. L.; Shakya, G.; Mih, N.; Townsend, 
C. A.; Burkart, M. D.; Tsai, S. C., Probing the selectivity and protein.protein interactions 
of a nonreducing fungal polyketide synthase using mechanism-based crosslinkers. Chem. 
Biol. 2013, 20 (9), 1135-46. 
27. Weissman, K. J.; Leadlay, P. F., Combinatorial biosynthesis of reduced 
polyketides. Nat. Rev. Microbiol. 2005, 3 (12), 925-36. 
28. Helfrich, E. J.; Piel, J., Biosynthesis of polyketides by trans-AT polyketide 
synthases. Nat. Prod. Rep. 2016, 33 (2), 231-316. 
 95 
29. Ma, S. M.; Li, J. W.; Choi, J. W.; Zhou, H.; Lee, K. K.; Moorthie, V. A.; Xie, X.; 
Kealey, J. T.; Da Silva, N. A.; Vederas, J. C.; Tang, Y., Complete reconstitution of a 
highly reducing iterative polyketide synthase. Science 2009, 326 (5952), 589-92. 
30. Vagstad, A. L.; Hill, E. A.; Labonte, J. W.; Townsend, C. A., Characterization of 
a fungal thioesterase having Claisen cyclase and deacetylase activities in melanin 
biosynthesis. Chem. Biol. 2012, 19 (12), 1525-34. 
31. Newman, A. G.; Vagstad, A. L.; Belecki, K.; Scheerer, J. R.; Townsend, C. A., 
Analysis of the cercosporin polyketide synthase CTB1 reveals a new fungal thioesterase 
function. Chem Commun (Camb) 2012, 48 (96), 11772-4. 
32. Schneider, C. A.; Rasband, W. S.; Eliceiri, K. W., NIH Image to ImageJ: 25 years 
of image analysis. Nat. Methods 2012, 9 (7), 671-5. 
 
 96 




Table A1: Primers used in this work. 
























































UMA-guided domain dissection 
 
UMAv2.18 was used with the BLOUSUM62 matrix. Secondary structure predictions 
were generated with ProteinPredict ((Yachdav et al., 2014), 
https://www.predictprotein.org/). Comparative sequences were curated from NCBI using 
the Conserved Domain Architecture Retrieval Tool (Geer et al., 2002) with PksCT as the 
query and included the following entries: XP_001217248, ANID_07903, ANID_00523, 
CAN87161, XP_001273475, XP_002381902, EHA28237, XP_001818926, 
XP_001393501, CAK40124, XP_660990.1, XP_658638.1, AAR90253.1, BAE66025.1, 
XP_001243185.1, CAK48487.1, XP_001559289.1, XP_002149737.1, XP_002567553.1, 
XP_002487778.1, XP_002340070.1, XP_002384396.1, XP_002848394.1, 












Figure A1: Exon revision and starter unit verification for PksCT.  
A) Five independent clones amplified from a cDNA library generated from total RNA 
under citrinin producing conditions. Each clone exactly matched the FGENESH 
prediction for the exon 1:exon 2 boundary.  
B) Radiolabel assay of acetyl starter unit transfer in PksCT. Lane 1: PksCT SAT, Lane 2: 
PksCT SAT + ACP without Sfp activation, Lane 3: PksCT SAT + ACP with Sfp 
activation. NR-PKS ACP domains are often partially phosphopantetheinylated during 
















Table A2: Plasmids used in this work: 
PksCT 
domain(s) 
Sequence Plasmid name Parent vector Tag MW 
(kDa) 
SAT M1-G380 pEMpPksCT-SAT pET-24a C-His6 41.8 
SAT-KS-MAT M1-I1288 pEMpPksCT-SKM3 pET-24a C-His6 144.0 
PT T1285-G1651 pEMpPksCT-PT pET-24a C-His6 41.5 
ACP T1652-G1779 pEMpPksCT-ACP pET-24a C-His6 15.0 
CMeT V1780-D2182 pEMpPksCT-CMeT pET-24a C-His6 46.6 
CMeT-Y1955A V1780-D2182 pEMpPksCT-CMeT-
Y1955A 
pET-24a C-His6 46.6 
CMeT-Y1955F V1780-D2182 pEMpPksCT-CMeT-
Y1955F 
pET-24a C-His6 46.6 
CMeT-H2067A V1780-D2182 pEMpPksCT-CMeT-
H2067A 
pET-24a C-His6 46.6 
CMeT-H2067Q V1780-D2182 pEMpPksCT-CMeT-
H2067Q 
pET-24a C-His6 46.6 


















Table A3: Crystallographic data collection and refinement statistics. 
 CMeT native CMeT SeMet 
Data collection    
Space group H3 H3† H3† 
Cell dimensions    
    a, b, c (Å) 98.37, 98.37, 133.43 98.52, 98.52, 133.20 98.13, 98.13, 124.45 
    α, β, γ  (°)  90.0, 90.0, 120.0 90.0, 90.0, 120.0 90.0, 90.0, 120.0 
Wavelength (Å) 0.99998 1.90747 0.97929 
Swipes 1 2 2 
Resolution (Å) 71.80 – 1.65‡ 71.85 - 2.05 50.21 – 1.85 
Rmerge (%)* 8.0 (159.6) 8.4 (102.9) 13.5 (274.2) 
I/σI* 10.61 (1.37) 15.62 (1.38) 13.75 (1.12) 
CC1/2 (%)* 99.9 (76.0) 99.8 (71.1) 99.9 (57.1) 
Completeness 
(%)* 
98.9 (94.3) 97.9 (81.7) 99.8 (99.7) 
Redundancy* 6.6 (6.6) 8.5 (2.6) 10.4 (10.2) 
Unique 
reflections* 
57,453 (4,045) 59,253 (3,685) 76,184 (5,646) 
    
Refinement    
Resolution (Å) 71.80 – 1.65   
Rwork/ Rfree 0.19 / 0.22   
Ramachandran 
favored / outlier 
(%) 
99.48 / 0.00   
No. atoms 6,512   
    Protein 6,173   
    Ligand 45   
    Solvent 294   
B-factors 36.22   
    Protein (Å2) 36.29   
    Ligand (Å2) 26.84   
    Solvent (Å2) 36.11   
R.m.s deviations    
    Bond lengths 
(Å)  
0.009   
    Bond angles 
(º) 
0.975   
The resolution cutoff was determined by CC1/2 criterion (Karplus and Diederichs, 2012). 
*, Highest resolution shell is shown in parenthesis. Datasets of native CMeT were 
acquired from the same crystal. †Anomalous data processing was applied. ‡A deprecated 
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conservative resolution cutoff at I/σI=2.91 and Rmerge= 69.8% is reached at a resolution 
of 1.84 Å. 
 
 







Table A4: Detected masses for compounds 2-8.  
 
# Calculated [MH+] or 
[MNa+] m/z 
Detected m/z (ppm) Formula 
2 237.1127 237.1121(2.53) C13H17O4 
3 127.0395 127.0391 (3.15) C6H7O3 


























7 141.0552 141.0553 (0.71) C7H9O3 




Figure A3:. Uncharacterized ligand and anomalous difference density. 
 
 
 (A) The active site tunnel reveals significant FO-FC omit difference density at 2.5 σ 
(brown) with a featured shape, which does not match components of the crystallization 
condition. Anomalous difference density at 3.7 σ (pink), indicates the presence of sulfur 
in methionine and cysteine residues as well as in SAH, but no significant difference 
density as part of the ligand.  
(B) The close up view on the active site reveals the expansion of the ligand’s difference 
density along the central tunnel with its end in the junction to the extended substrate 
cavity. The same contour level of the SAH difference density (blue) suggests either a 
partial occupancy or various conformations of the less defined ligand. The extent of 
difference density corresponds approximately to an atomistic binding interface of 500 Å2. 
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Figure A4: Revised M. purpureus PksCT sequence.  
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Appendix B: Supplementary Material for Chapter 3. 
 
Figure B1: Protein sequences for NR-PKSs used in this work.  









































































































































































































































Table B1: Primers used in this work. 
 
See Appendix A for PksCT primers 
 































































































Table B2: Plasmids used in this work: 
 
See Appendix A for PksCT plasmids 
 




M1-N1286 pEAnPkeA-SKM pET-24a C-His6 142.2 
PkeA ACP S1650-S1783 pEAnPkeA-ACP pET-24a C-His6 15.7 
PkeA CMeT M1784-S2183 pEAnPkeA-CMeT pET-24a C-His6 46.8 
AusA ACP S1626-I1737 pEAnAusA-ACP pET-24a C-His6 13.0 
AusA CMeT S1738-P2123 pEAnAusA-CMeT pET-24a C-His6 44.6 
DtbA ACP2 G1619-S1853 pEDtbA-ACP pET-24a C-His6 27.0 
DtbA CMeT V1847-S2239 pEDtbA-CMeT pET-24a C-His6 45.2 























































Table B3: Detected masses for compounds 1-12.  
 
# Calculated [MH+] or 
[MNa+] m/z 
Detected m/z (ppm) Formula 







3 141.0552 141.0553 (0.71) C7H9O3 
4 155.0708 155.0704 (2.58) C8H11O3 

















































12 141.0552 141.0552 (0) C7H9O3 
 





Appendix C: Supplementary Material for Chapter C. 
 
Table C1: Primers used in this work 




































Table C2: Plasmids used 





CitA pEMpOrf4v2 pET-24a C-His6 30.7 This work 
CitA-S122A pEMpOrf4v2-
S122A 
pET-24a C-His6 30.7 This work 
CitA-R36A pEMpOrf4v2-
R36A 
pET-24a C-His6 30.7 This work 
CitA-R236A pEMpOrf4v2-
R236A 





pET-24a C-His6 144.0 Appendix A 
PksCT PT pEMpPksCT-PT pET-24a C-His6 41.5 Appendix A 
PksCT ACP pEMpPksCT-ACP pET-24a C-His6 15.0 Appendix A 
PksCT CMeT pEMpPksCT-
CMeT 
pET-24a C-His6 46.6 Appendix A 
PksCT CMeT-R pEMpPksCT-
CMeT-R 



















Figure C1: SDS-PAGE of PksCT ACP, CitA, and CitA mutants. 
Separation of purified PksCT ACP and CitA by SDS-PAGE (16%) to show purity, with 5 
µL per lane at 2 mg/mL total protein. M: BenchMark ladder (Invitrogen), with 50 and 20 






















Figure C2: UPLC-ESI-MS data for apo-ACPCT. 



















































Figure C3. UPLC-ESI-MS data for Mal-holo-ACPCT 


































Figure C4. UPLC-ESI-MS data for Acac-holo-ACPCT 


































Figure C5. UPLC-ESI-MS data for Mal-holo-ACPCT + CitA 
































Figure C6. UPLC-ESI-MS data for Acac-holo-ACPCT + CitA 
























































Figure C8: UPLC-ESI-MS data for Mal-holo-ACPCT/Acac-holo-ACPCT + 
CitA 


































































 108  ALA
 158  ALA
 167  ASP
 222  ALA
 234  ASP
General/Pre-Pro/Proline Favoured General/Pre-Pro/Proline Allowed
Glycine Favoured Glycine Allowed
Number of residues in favoured region (~98.0% expected) :  207  (85.5%)
Number of residues in allowed region (~2.0% expected) :  30  (12.4%)
Number of residues in outlier region :  5  (2.1%)
RAMPAGE by Paul de Bakker and Simon Lovell available at http://www-cryst.bioc.cam.ac.uk/rampage/ 
Please cite: S.C. Lovell, I.W. Davis, W.B. Arendall III, P.I.W. de Bakker, J.M. Word, M.G. Prisant, J.S. Richardson & D.C. Richardson (2002)
Structure validation by C_ geometry: q/s and C` deviation. Proteins: Structure, Function & Genetics. 50: 437-450
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